Pädiatrie 5

Publikationen

Bücherregal

2019

Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy. 
Calaminus G, Jenney M, Hjorth L, Baust K, Bernstein M, Bielack S, Vos P, Hogendoorn PCW, Jovic G, Krailo M, Kreitz K, Marina N, Popoola BO, Sauerland C, Smeland S, Teske C, Schweinitz CV, Whelan J, Wiener A, Sydes MR, Nagarajan R. JMIR Res Protoc. 2019 Sep 26;8(8):e14406. doi: 10.2196/14406.
 

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. 
Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N. Eur J Cancer. 2019 Mar;109:36-50. doi: 10.1016/j.ejca.2018.11.027. Epub 2019 Jan 25.
 

Diagnostik und Therapieoptionen bei Osteosarkomen 
Hecker-Nolting S, Bielack S.
pädiatrische praxis. 2019; 91/2: 234-247
chirurgische praxis. 2019; 85: 640-653
 

Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
Bielack SS
, Cox MC, Nathrath M, Apel K, Blattmann C, Holl T, Jenewein R, Klenk U, Klothaki P, Müller-Abt P, Ortega-Lawerenz S, Reynolds M, Scheer M, Simon-Klingenstein K, Stegmaier S, Tupper R, Vokuhl C, von Kalle T.
Ann Oncol. 2019 Nov;30 Suppl 8:viii31-viii35. doi: 10.1093/annonc/mdz382. Epub 2019 Dec 24.
 

Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma.
Desch AK, Hartung K, Botzen A, Brobeil A, Rummel M, Kurch L, Georgi T, Jox T, BielackS, Burdach S, Classen CF, Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW, Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A, Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz R, Kluge R, Mauz-Körholz C, Körholz D, Gattenlöhner S, Bräuninger A. Leukemia. 2020 Jan;34(1):151-166. doi: 10.1038/s41375-019-0541-6. Epub 2019 Aug 20.
 

The German National Registry of Primary Immunodeficiencies (2012-2017).
El-Helou SM, Biegner AK, Bode S, Ehl SR, Heeg M, Maccari ME, Ritterbusch H, Speckmann C, Rusch S, Scheible R, Warnatz K, Atschekzei F, Beider R, Ernst D, Gerschmann S, Jablonka A, Mielke G, Schmidt RE, Schürmann G, Sogkas G, Baumann UH, Klemann C, Viemann D, von Bernuth H, Krüger R, Hanitsch LG, Scheibenbogen CM, Wittke K, Albert MH, Eichinger A, Hauck F, Klein C, Rack-Hoch A, Sollinger FM, Avila A, Borte M, Borte S, Fasshauer M, Hauenherm A, Kellner N, Müller AH, Ülzen A, Bader P, Bakhtiar S, Lee JY, Heß U, Schubert R, Wölke S, Zielen S, Ghosh S, Laws HJ, Neubert J, Oommen PT, Hönig M, Schulz A, Steinmann S, Schwarz K, Dückers G, Lamers B, Langemeyer V, Niehues T, Shai S, Graf D, Müglich C, Schmalzing MT, Schwaneck EC, Tony HP, Dirks J, Haase G, Liese JG, Morbach H, Foell D, Hellige A, Wittkowski H, Masjosthusmann K, Mohr M, Geberzahn L, Hedrich CM, Müller C, Rösen-Wolff A, Roesler J, Zimmermann A, Behrends U, Rieber N, Schauer U, Handgretinger R, Holzer U, Henes J, Kanz L, Boesecke C, Rockstroh JK, Schwarze-Zander C, Wasmuth JC, Dilloo D, Hülsmann B, Schönberger S, Schreiber S, Zeuner R, Ankermann T, von Bismarck P, Huppertz HI, Kaiser-Labusch P, Greil J, Jakoby D, Kulozik AE, Metzler M, Naumann-Bartsch N, Sobik B, Graf N, Heine S, Kobbe R, Lehmberg K, Müller I, Herrmann F, Horneff G, Klein A, Peitz J, Schmidt N, Bielack S, Groß-Wieltsch U, Classen CF, Klasen J, Deutz P, Kamitz D, Lassay L, Tenbrock K, Wagner N, Bernbeck B, Brummel B, Lara-Villacanas E, Münstermann E, Schneider DT, Tietsch N, Westkemper M, Weiß M, Kramm C, Kühnle I, Kullmann S, Girschick H, Specker C, Vinnemeier-Laubenthal E, Haenicke H, Schulz C, Schweigerer L, Müller TG, Stiefel M, Belohradsky BH, Soetedjo V, Kindle G, Grimbacher B.
Front Immunol. 2019 Jul 19;10:1272. doi: 10.3389/fimmu.2019.01272. eCollection 2019.
 

Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia survey.
Li CK, Dalvi R, Yonemori K, Ariffin H, Lyu CJ, Farid M, Gonzales-Santos JRN, Zhou Q, Bielack S, Brugieres L, Blondeel A, Essiaf S, Peccatori FA, Jezdic S, Stark DP, Douillard JY, Saloustros E, Mountzios G.
ESMO Open. 2019 Jun 6;4(3):e000467. doi: 10.1136/esmoopen-2018-000467. eCollection 2019.
 

Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M
, Koscielniak E, Vokuhl C, Schmid I, Bien E, Seitz G, Hallmen E, von Kalle T, Scheer M, Münter M, Bielack SS, Niggli F, Ljungman G, Fuchs J, Hettmer S, Rössler J, Klingebiel T; CWS Study Group.
Pediatr Blood Cancer. 2020 Mar;67(3):e28095. doi: 10.1002/pbc.28095. Epub 2019 Dec 8.
 

The Impact of Local Control in the Treatment of Children with Advanced Infantile and Adult-Type Fibrosarcoma: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sparber-Sauer M
, Vokuhl C, Seitz G, Stegmaier S, Hallmen E, von Kalle T, Scheer M, Münter M, Bielack SS, Ladenstein R, Niggli F, Ljungman G, Fuchs J, Klingebiel T, Koscielniak E; CWS Study Group.
J Pediatr Surg. 2019 Nov 9. pii: S0022-3468(19)30786-9. doi:
10.1016/j.jpedsurg.2019.10.051. [Epub ahead of print]
 

Low-grade fibromyxoid sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Scheer M
, Vokuhl C, Veit-Friedrich I, Münter M, von Kalle T, Greulich M, Loff S, Stegmaier S, Sparber-Sauer M, Niggli F, Ladenstein R, Kazanowska B, Ljungman G, Jahnukainen K, Fuchs J, Bielack SS, Koscielniak E, Klingebiel T; Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatr Blood Cancer. 2020 Feb;67(2):e28009. doi: 10.1002/pbc.28009. Epub 2019 Nov 17.
 

Epithelioid sarcoma in children, adolescents, and young adults: Localized, primary metastatic and relapsed disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M
, Koscielniak E, Vokuhl C, Seitz G, Hallmen E, von Kalle T, Scheer M, Münter M, Bielack SS, Ladenstein R, Fuchs J, Klingebiel T; CWS Study Group.
Pediatr Blood Cancer. 2019 Sep;66(9):e27879. doi: 10.1002/pbc.27879. Epub 2019 Jun 19.
 

Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sparber-Sauer M
, Stegmaier S, Vokuhl C, Seitz G, von Kalle T, Scheer M, Münter M, Bielack SS, Weclawek-Tompol J, Ladenstein R, Niggli F, Ljungman G, Fuchs J, Hettmer S, Koscielniak E, Klingebiel T; CWS Study Group.
Pediatr Blood Cancer. 2019 Jun;66(6):e27652. doi: 10.1002/pbc.27652. Epub 2019 Feb 14.
 

Desmoplastic small round cell tumors: Multimodality treatment and new risk factors.
Scheer M
, Vokuhl C, Blank B, Hallmen E, von Kalle T, Münter M, Wessalowski R, Hartwig M, Sparber-Sauer M, Schlegel PG, Kramm CM, Kontny U, Spriewald B, Kegel T, Bauer S, Kazanowska B, Niggli F, Ladenstein R, Ljungman G, Jahnukainen K, Fuchs J, Bielack SS, Klingebiel T, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe [CWS].
Cancer Med. 2019 Feb;8(2):527-542. doi: 10.1002/cam4.1940. Epub 2019 Jan 16.
 

Localized synovial sarcoma of the foot or ankle: A series of 32 Cooperative
Weichteilsarkom Study Group patients.
Scheer M
, Greulich M, Loff S, Vokuhl C, Feuchtgruber S, von Kalle T, Münter M, Stegmaier S, Sparber-Sauer M, Kazanowska B, Niggli F, Fuchs J, Bielack SS, Klingebiel T, Koscielniak E; and the other members of the Cooperative Weichteilsarkom Studiengruppe (CWS) Group. J Surg Oncol. 2019 Jan;119(1):109-119. doi: 10.1002/jso.25284. Epub 2018 Nov 13.
 

In Reply to Gultekin and Yildiz. Doyen J, Jazmati D, Geismar D, Frisch S, Schulze Schleithoff S, Vermeren X, Scheer M, Blasé C, Tippelt S, Timmermann B. Int J Radiat Oncol Biol
Phys. 2019 Dec 1;105(5):1164-1165. doi: 10.1016/j.ijrobp.2019.09.032. PubMed PMID:31748140.


Current and Future Treatment Strategies for Rhabdomyosarcoma.Chen C, Dorado Garcia H, Scheer M, Henssen AG. Front Oncol. 2019 Dec 20;9:1458. doi: 10.3389/fonc.2019.01458. eCollection 2019. Review. PubMed PMID: 31921698; PubMed Central PMCID: PMC6933601. Scheer M, Blank B, Bauer S, Vokuhl C, Stegmaier S, Feuchtgruber S, Henssen A, Sparber-Sauer M, Eggert A, Handgretinger R, Pekrun A, Rossig C, Rutkowski S, Schlegel PG, Schrappe M, Simon T, Kazanowska B, Niggli F, Ladenstein R, Ljungman G, Jahnukainen K, Fuchs J, Bielack SS, Koscielniak E, Klingebiel T; Cooperative Weichteilsarkom Studiengruppe [CWS].
 

Synovial sarcoma disease characteristics and primary tumor sites differ between patient age groups: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS). J Cancer Res Clin Oncol. 2020 Jan 13. doi: 10.1007/s00432-019-03121-9. [Epub ahead of print] PubMed PMID: 31932909.
 

Outcome and patterns of relapse in childhood parameningeal rhabdomyosarcoma treated with proton beam therapy.Doyen J, Jazmati D, Geismar D, Frisch S, Schleithoff SS, Vermeren X, Scheer M, Blase C, Tippelt S, Timmermann B. Int J Radiat Oncol Biol Phys. 2019 Aug 13. pii: S0360-3016(19)33638-7. doi: 10.1016/j.ijrobp.2019.08.005. [Epub ahead of print] PubMed PMID: 31419513.


CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma. Kather JN, Hörner C, Weis CA, Aung T, Vokuhl C, Weiss C, Scheer M, Marx A, Simon-Keller K. Sci Rep. 2019 Jun 25;9(1):9211.
doi: 10.1038/s41598-019-45551-y. PubMed PMID: 31239476; PubMed Central PMCID: PMC6592899.
 

Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS). Urla C, Warmann SW, Sparber-Sauer M, Schuck A, Leuschner I, Klingebiel T, Blumenstock G, Seitz G, Koscielniak E, Fuchs J. BMC Cancer. 2019 Oct 14;19(1):945. doi: 10.1186/s12885-019-6172-5.
 

Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS-81, -86, -91, -96, and -2002P trials.Seitz G, Urla C, Sparber-Sauer M, Schuck A, Vokuhl C, Blank B, Klingebiel T, Kazanowska B, Fuchs J, Koscielniak E. Pediatr Blood Cancer. 2019 Aug;66 Suppl 3:e27884. doi: 10.1002/pbc.27884.
 

Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS-81, -86, -91, -96, and -2002P trials.Seitz G, Urla C, Sparber-Sauer M, Schuck A, Vokuhl C, Blank B, Klingebiel T, Kazanowska B, Fuchs J, Koscielniak E. Pediatr Blood Cancer. 2019 Mar;66(3):e27537. doi: 10.1002/pbc.27537. Epub 2018 Nov 12. Corrected and republished in: Pediatr Blood Cancer. 2019 Aug;66 Suppl 3:e27884.
 

Challenging News: Pädiatrische Hämatologie und Onkologie. Neue Therapieansätze bei seltenen Erkrankungen. M. Sparber-Sauer und S. Bielack. Klinikarzt 2019; 48: 577-582. doi 10.1055/a-1063-5393.
 

Leben mit Krebs –Nachsorgeprogramm für junge Krebspatienten. B. Koch, J Salchow, S. Elmers, J.Mann, A. Beitzen-Heineke, W. Jensen, J. von Grundherr, G. Escherich, T. Boesten, C.Bergelt, S.Dwinger, C.Bokemeyer,
M. Sokalska-Duhme, G.Calaminus, K.Baust³, C.F.Classen, A. Mirau, J.Faber, H.Faller, I.Hilgendorf, T.Langer, J.Gebauer, M.Metzler, A.Puzik,  D.Reinhardt, U.Dirksen,A.Sander, M.Köhler, A.Stein. Onkologische Pharmazie, 21.Jahrgang Nr.3/2019
 

Germline RET variants underlie a subset of paediatric osteosarcoma.Kovac M, Woolley C, Ribi S, Blattmann C, Roth E, Morini M, Kovacova M, Ameline B, Kulozik A, Bielack S, Hartmann W, Ballinger ML, Thomas DM, Tomlinson I, Nathrath M, Heinimann K, Baumhoer D. J Med Genet. 2020 Mar 16. pii: jmedgenet-2019-106734.
 

Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient-derived osteosarcoma cells and synergizes with cisplatin and talazoparib. Heidler CL, Roth EK, Thiemann M, Blattmann C, Perez RL, Huber PE, Kovac M, Amthor B, Neu-Yilik G, Kulozik AE. Int J Cancer. 2019 Nov 28. doi: 10.1002/ijc.32814. [Epub ahead of print]
 

Repertoire Sequencing of B Cells Elucidates the Role of UNG and Mismatch Repair Proteins in Somatic Hypermutation in Humans. IJspeert H, van Schouwenburg PA, Pico-Knijnenburg I, Loeffen J, Brugieres L, Driessen GJ, Blattmann C, Suerink M, Januszkiewicz-Lewandowska D, Azizi AA, Seidel MG, Jacobs H, van der Burg M. Front Immunol. 2019 Aug 27;10:1913.

2018

Arndt CAS, Bisogno G, Koscielniak E.
Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned.
Cancer Treat Rev. 2018 Jul;68:94-101. doi: 10.1016/j.ctrv.2018.06.013. Epub 2018 Jun 19.

Berthold F, Ernst A, Hero B, Klingebiel T, Kremens B, Schilling FH, Simon T.
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation.
Br J Cancer. 2018 Aug;119(3):282-290. doi: 10.1038/s41416-018-0169-8. Epub 2018 Jul 11.

Bielack S, Hecker-Nolting S, Kevric M, Sorg B, Blattmann C.
Osteosarkome bei Kindern und Jugendlichen.
Aktuelle Gesundheits-Nachrichten 28:7-19,2018

Blattmann C, Hecker-Nolting S, Bielack S.
Treatment of nonmetastatic osteosarcoma.
In Castellanos-Toledo A, Martinez-Ávalos A, Rodriguez-Jurado RR (eds.): Osteosarcoma, 2nd ed.. Mexico City, 2018

Byrne J, Grabow D, Campbell H, O'Brien K, Bielack S, Am Zehnhoff-Dinnesen A, Calaminus G, Kremer L, Langer T, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, Baust K, Bautz A, Beck JD, Berger C, Binder H, Borgmann-Staudt A, Broer L, Cario H, Casagranda L, Clemens E, Deuster D, de Vries A, Dirksen U, Falck Winther J, Fosså S, Font-Gonzalez A, Grandage V, Haupt R, Hecker-Nolting S, Hjorth L, Kaiser M, Kenborg L, Kepak T, Kepáková K, Knudsen LE, Krawczuk-Rybak M, Kruseova J, Kuehni CE, Kunstreich M, Kuonen R, Lackner H, Leiper A, Loeffen EAH, Luks A, Modan-Moses D, Mulder R, Parfitt R, Paul NW, Ranft A, Ruud E, Schilling R, Spix C, Stefanowicz J, Strauβ G, Uitterlinden AG, van den Berg M, van der Kooi AL, van Dijk M, van Leeuwen F, Zolk O, Zöller D, Kaatsch P;
PanCareLIFE consortium. PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents.
Eur J Cancer. 2018 Nov;103:227-237. doi: 10.1016/j.ejca.2018.08.007. Epub 2018 Sep 29.

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY;
ESMO Guidelines Committee and EURACAN. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2018 Oct 1;29(Supplement_4):iv267. doi: 10.1093/annonc/mdy320

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY;
ESMO Guidelines Committee and EURACAN. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2018 Oct 1;29(Supplement_4):iv268-iv269. doi: 10.1093/annonc/mdy321. No abstract available.

Casali PG*, Bielack S*, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S, Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugières L, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gaspar N, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hecker-Nolting S, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kager L, Kasper B, Kopeckova K, Krákorová DA, Ladenstein R, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Morland B, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Strauss SJ, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY;
ESMO Guidelines Committee, PaedCan and ERN EURACAN. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2018 Oct 1;29(Supplement_4):iv79-iv95. doi: 10.1093/annonc/mdy310. * both authors contributed equally

Dantonello TM, Vokuhl C, Scheer M, Sparber-Sauer M, Stegmaier S, Seitz G, Scheithauer H, Faber J, Veit-Friedrich I, Kaatsch P, Bielack SS, Klingebiel T, Koscielniak E;
Cooperative Weichteilsarkom Studiengruppe (CWS). Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis?
Virchows Arch. 2018 Mar;472(3):441-449. doi: 10.1007/s00428-018-2311-7. Epub 2018

Ferrari S, Bielack SS, Smeland S, Longhi A, Egerer G, Sundby Hall K, Donati D, Kevric M, Brosjö O, Comandone A, Werner M, Monge O, Palmerini E, Berdel WE, Bjerkehagen B, Paioli A, Lorenzen S, Eriksson M, Gambarotti M, Tunn PU, Jebsen NL, Cesari M, von Kalle T, Ferraresi V, Schwarz R, Bertulli R, Kasparek AK, Grignani G, Krasniqi F, Sorg B, Hecker-Nolting S, Picci P, Reichardt P.
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Tumori. 2018 Jan-Feb;104(1):30-36. doi: 10.5301/tj.5000696

Fuchs J, Urla C, Sparber-Sauer M, Schuck A, Leuschner I, Klingebiel T, Blumenstock G, Seitz G, Koscielniak E.
Treatment and outcome of patients with localized intrathoracic and chest wall rhabdomyosarcoma: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
J Cancer Res Clin Oncol. 2018 May;144(5):925-934. doi: 10.1007/s00432-018-2603-y. Epub 2018 Feb 20.

Goebel AM, Koustenis E, Rueckriegel SM, Pfuhlmann L, Brandsma R, Sival D, Skarabis H, Schuelke M, Hernáiz Driever P.
Motor function in survivors of pediatric acute lymphoblastic leukemia treated with chemotherapy-only.
Eur J Paediatr Neurol. 2018 Dec 17. pii: S1090-3798(18)30027-8. doi: 10.1016/j.ejpn.2018.12.005. [Epub ahead of print]

Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H, Burkhardt B, Kratz CP, Witt O, van Tilburg CM, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Frühwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM;
ICGC PedBrain-Seq Project; ICGC MMML-Seq Project. The landscape of genomic alterations across childhood cancers.
Nature. 2018 Mar 15;555(7696):321-327. doi: 10.1038/nature25480. Epub 2018 Feb 28.

Hecker-Nolting S, Bielack S.
Diagnostik und Therapieoptionen bei Osteosarkomen.
ONKOLOGIE heute 12/2018, 61-68

Heinemann M, Ranft A, Langer T, Jürgens H, Kreyer J, Vieth V, Schäfers M, Weckesser M, Simon T, Hassenpflug W, Corbacioglu S, Bielack S, Mayer-Steinacker R, Kühne T, van den Berg H, Gelderblom H, Bauer S, Stegger L, Dirksen U.
Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?
Pediatr Blood Cancer. 2018 Jul;65(7):e27011. doi: 10.1002/pbc.27011. Epub 2018 Feb 26.

Kager L, Bielack S. Osteosarkome. Pp 509-525 in Niemeyer C, Eggert A (Hrsg.):
Pädiatrische Hämatologie und Onkologie,
2. Auflage. Springer, Berlin, Heidelberg 2018. ISBN 978-3-662-43685-1

Kube S, Vokuhl C, Dantonello T, Scheer M, Hallmen E, Feuchtgruber S, Escherich G, Niggli F, Kuehnle I, von Kalle T, Bielack S, Klingebiel T, Koscielniak E.
Inflammatory myofibroblastic tumors-A retrospective analysis of the Cooperative Weichteilsarkom Studiengruppe.
Pediatr Blood Cancer. 2018 Jun;65(6):e27012. doi: 10.1002/pbc.27012. Epub 2018 Feb 26.

Merker M, Meister MT, Rettinger E, Jarisch A, Soerensen J, Willasch A, Huenecke S, Cappel C, Bremm M, Salzmann-Manrique E, Krenn T, Rossig C, Kremens B, Koscielniak E, Klingebiel T, Bader P.
No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency. Bone Marrow Transplant.
2018 Jul;53(7):891-894. doi: 10.1038/s41409-018-0088-6. Epub 2018 Jan 24.

Scheer M, Dantonello T, Brossart P, Dilloo D, Schweigerer L, Feuchtgruber S, Sparber-Sauer M, Vokuhl C, Bielack SS, Klingebiel T, Koscielniak E, von Kalle T;
Cooperative Weichteilsarkom Studiengruppe (CWS). Importance of whole-body imaging with complete coverage of hands and feet in alveolar rhabdomyosarcoma staging.
Pediatr Radiol. 2018 May;48(5):648-657. doi: 10.1007/s00247-017-4066-8. Epub 2018 Jan 24.

Scheer M, Greulich M, Loff S, Vokuhl C, Feuchtgruber S, von Kalle T, Münter M, Stegmaier S, Sparber-Sauer M, Kazanowska B, Niggli F, Fuchs J, Bielack SS, Klingebiel T, Koscielniak E; and the other members of the Cooperative Weichteilsarkom Studiengruppe (CWS) Group.
Localized synovial sarcoma of the foot or ankle: A series of 32 Cooperative Weichteilsarkom Study Group patients.
J Surg Oncol. 2019 Jan;119(1):109-119. doi: 10.1002/jso.25284. Epub 2018 Nov 13.

Scheer M, Vokuhl C, Blank B, Hallmen E, von Kalle T, Münter M, Wessalowski R, Hartwig M, Sparber-Sauer M, Schlegel PG, Kramm CM, Kontny U, Spriewald B, Kegel T, Bauer S, Kazanowska B, Niggli F, Ladenstein R, Ljungman G, Jahnukainen K, Fuchs J, Bielack SS, Klingebiel T, Koscielniak E;
Cooperative Weichteilsarkom Studiengruppe [CWS].
Desmoplastic small round cell tumors: Multimodality treatment and new risk factors.
Cancer Med. 2019 Jan 16. doi: 10.1002/cam4.1940. [Epub ahead of print]

Schmid I, Klenk AK, Sparber-Sauer M, Koscielniak E, Maxwell R, Häberle B.
Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
World J Pediatr. 2018 Aug;14(4):322-329. doi: 10.1007/s12519-018-0171-5. Epub 2018 Jul 27.

Schuster AJ, Kager L, Reichardt P, Baumhoer D, Csóka M, Hecker-Nolting S, Lang S, Lorenzen S, Mayer-Steinacker R, von Kalle T, Kevric M, Werner M, Windhager R, Wirth T, Bielack SS.
High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients.
Sarcoma. 2018 May 2;2018:1632978. doi: 10.1155/2018/1632978. eCollection 2018.

Seitz G, Urla C, Sparber-Sauer M, Schuck A, Vokuhl C, Blank B, Klingebiel T, Kazanowska B, Fuchs J, Koscielniak E.
Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS-81, -86, -91, -96, and -2002P trials.
Pediatr Blood Cancer. 2018 Nov 12:e27537. doi: 10.1002/pbc.27537. [Epub ahead of print]

Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N.
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
Eur J Cancer. 2019 Jan 24;109:36-50. doi: 10.1016/j.ejca.2018.11.027. [Epub ahead of print]

Sparber-Sauer M, Bielack S. ASCO 2018:
Neues in der pädiatrischen Onkologie.
klinikarzt 47:618-624, 2018

Sparber-Sauer M, Seitz G, von Kalle T, Vokuhl C, Leuschner I, Scheer M, Münter M, Ljungman G, Bielack SS, Niggli F, Ladenstein R, Klingebiel T, Fuchs J, Koscielniak E; CWS Study Group.
Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Pediatr Blood Cancer. 2018 May;65(5):e26943. doi: 10.1002/pbc.26943. Epub 2018 Jan 5.

Sparber-Sauer M, Seitz G, von Kalle T, Vokuhl C, Scheer M, Münter M, Bielack SS, Kazanowska B, Ladenstein R, Niggli F, Klingebiel T, Fuchs J, Koscielniak E; CWS Study Group.
Alveolar soft-part sarcoma: Primary metastatic disease and metastatic relapse occurring during long-term follow-up: Treatment results of four Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Pediatr Blood Cancer. 2018 Dec;65(12):e27405. doi: 10.1002/pbc.27405. Epub 2018 Aug 19.

Strauss SJ, Anninga J, Baglio R, Baumhoer D, Behjati S, Bielack S, Boye K, Broto JM, Cleton‑Jansen AM, Degasperi A, Evans A, Fagioli F, Fiocco M, Gaspar N, Heymann D, Hindi N, Lancia C, Myklebost O, Nathrath M, Redini F, Scotlandi K, Tirtei E, Vanden Eynden M, Whelan J.
Report from the 4th European Bone Sarcoma Networking meeting: focus on osteosarcoma.
Clin Sarcoma Res (2018) 8:17 doi: 10.1186/s13569-018-0103-0

Suttorp M, Schulze P, Glauche I, Göhring G, von Neuhoff N, Metzler M, Sedlacek P, de Bont ESJM, Balduzzi A, Lausen B, Aleinikova O, Sufliarska S, Henze G, Strauss G, Eggert A, Kremens B, Groll AH, Berthold F, Klein C, Groß-Wieltsch U, Sykora KW, Borkhardt A, Kulozik AE, Schrappe M, Nowasz C, Krumbholz M, Tauer JT, Claviez A, Harbott J, Kreipe HH, Schlegelberger B, Thiede C.
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.
Leukemia. 2018 Jul;32(7):1657-1669. doi: 10.1038/s41375-018-0179-9. Epub 2018 Jun 20.

Tesch VK, IJspeert H, Raicht A, Rueda D, Dominguez-Pinilla N, Allende LM, Colas C, Rosenbaum T, Ilencikova D, Baris HN, Nathrath MHM, Suerink M, Januszkiewicz-Lewandowska D, Ragab I, Azizi AA, Wenzel SS, Zschocke J, Schwinger W, Kloor M, Blattmann C, Brugieres L, van der Burg M, Wimmer K, Seidel MG.
Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial.
Front Immunol. 2018 Jul 2;9:1506. doi: 10.3389/fimmu.2018.01506. eCollection 2018.

Walterhouse DO, Barkauskas DA, Hall D, Ferrari A, De Salvo GL, Koscielniak E, Stevens MCG, Martelli H, Seitz G, Rodeberg DA, Shnorhavorian M, Dasgupta R, Breneman JC, Anderson JR, Bergeron C, Bisogno G, Meyer WH, Hawkins DS, Minard-Colin V.
Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups.
J Clin Oncol. 2018 Oct 23:JCO2018789388. doi: 10.1200/JCO.2018.78.9388. [Epub ahead of print]

Wegener D, Lang P, Paulsen F, Weidner N, Zips D, Ebinger M, Holzer U, Döring M, Basu O, Gruhn B, Wittig A, Teltschik HM, Handgretinger R, Heinzelmann F.
Immunosuppressive TNI -based reconditioning regimens after graft rejection or graft failure in pediatric patients treated with myeloablative allogeneic hematopoietic cell transplantation.
Int J Radiat Oncol Biol Phys. 2018 Dec 26. pii: S0360-3016(18)34197-X. doi: 10.1016/j.ijrobp.2018.12.031. [Epub ahead of print]

Wegert J, Vokuhl C, Collord G, Del Castillo Velasco-Herrera M, Farndon SJ, Guzzo C, Jorgensen M, Anderson J, Slater O, Duncan C, Bausenwein S, Streitenberger H, Ziegler B, Furtwängler R, Graf N, Stratton MR, Campbell PJ, Jones DT, Koelsche C, Pfister SM, Mifsud W, Sebire N, Sparber-Sauer M, Koscielniak E, Rosenwald A, Gessler M, Behjati S.
Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nat Commun.
2018 Jun 18;9(1):2378. doi: 10.1038/s41467-018-04650-6.

Whelan J, Le Deley MC, Dirksen U, Le Teuff G, Brennan B, Gaspar N, Hawkins DS, Amler S, Bauer S, Bielack S, Blay JY, Burdach S, Castex MP, Dilloo D, Eggert A, Gelderblom H, Gentet JC, Hartmann W, Hassenpflug WA, Hjorth L, Jimenez M, Klingebiel T, Kontny U, Kruseova J, Ladenstein R, Laurence V, Lervat C, Marec-Berard P, Marreaud S, Michon J, Morland B, Paulussen M, Ranft A, Reichardt P, van den Berg H, Wheatley K, Judson I, Lewis I, Craft A, Juergens H, Oberlin O;
Euro-E.W.I.N.G.99 and EWING-2008 Investigators. High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.
J Clin Oncol. 2018 Sep 6:JCO2018782516. doi: 10.1200/JCO.2018.78.2516. [Epub ahead of print]

2017

Ammann S, Lehmberg K, Zur Stadt U, Klemann C, Bode SFN, Speckmann C, Janka G, Wustrau K, Rakhmanov M, Fuchs I, Hennies HC, Ehl S;
HLH study of the GPOH. Effective Immunological Guidance of
Genetic Analyses Including Exome Sequencing in Patients Evaluated for Hemophagocytic Lymphohistiocytosis.
J Clin Immunol. 2017 Nov;37(8):770-780.

Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, Delgado Bolton R, Donati DM, Douis H, Haas R, Hogendoorn P, Kozhaeva O, Lavender V, Lovey J, Negrouk A, Pereira P, Roca P, de Lempdes GR, Saarto T, van Berck B, Vassal G, Wartenberg M, Yared W, Costa A, Naredi P.
ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review.
Crit Rev Oncol Hematol. 2017 Feb;110:94-105.

Burkhardt L, Lobitz S, Koustenis E, Rueckriegel SM, Hernáiz Driever P.
Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin.
Ann Hematol. 2017 Feb;96(2):199-213.

Escherich G, Bielack S, Maier S, Braungart R, Brümmendorf TH, Freund M, Grosse R, Hoferer A, Kampschulte R, Koch B, Lauten M, Milani V, Ross H, Schilling F, Wöhrle D, Cario H, Dirksen U.
Building a National Framework for Adolescent and Young Adult Hematology and Oncology and Transition from Pediatric to Adult Care: Report of the Inaugural Meeting of the "AjET" Working Group of the German Society for Pediatric Oncology and Hematology.
J Adolesc Young Adult Oncol. 2017 Jun;6(2):194-199.

Ferrari S, Bielack SS, Smeland S, Longhi A, Egerer G, Sundby Hall K, Donati D, Kevric M, Brosjö O, Comandone A, Werner M, Monge O, Palmerini E, Berdel WE, Bjerkehagen B, Paioli A, Lorenzen S, Eriksson M, Gambarotti M, Tunn PU, Jebsen NL, Cesari M, von Kalle T, Ferraresi V, Schwarz R, Bertulli R, Kasparek AK, Grignani G, Krasniqi F, Sorg B, Hecker-Nolting S, Picci P, Reichardt P.
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Tumori. 2017 Dec 5:0.

Hettmer S, Andrieux G, Hochrein J, Kurz P, Rössler J, Lassmann S, Werner M, von Bubnoff N, Peters C, Koscielniak E, Sparber-Sauer M, Niemeyer C, Mentzel T, Busch H, Boerries M.
Epithelioid hemangioendotheliomas of the liver and lung in children and adolescents.
Pediatr Blood Cancer. 2017 Dec;64(12).

Kager L, Tamamyan G, Bielack S.
Novel insights and therapeutic interventions for pediatric osteosarcoma.
Future Oncol. 2017 Feb;13(4):357-368.

Kuhlen M, Bleckmann K, Möricke A, Schrappe M, Vieth S, Escherich G, Bronsema A, Vonalt A, Queudeville M, Zwaan CM, Ebinger M, Debatin KM, Klingebiel T, Koscielniak E, Rossig C, Burkhardt B, Kolb R, Eckert C, Borkhardt A, von Stackelberg A, Chen-Santel C.
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.
Br J Haematol. 2017 Oct;179(2):272-283.

Locatelli F, Valsecchi MG, Möricke A, Zimmermann M, Gruhn B, Biondi A, Kulozik AE, Silvestri D, Bodmer N, Putti MC, Burdach S, Micalizzi C, Teigler-Schlegel A, Ritter J, Pession A, Cario G, Bielack S, Basso G, Klingebiel T, Vinti L, Rizzari C, Attarbaschi A, Santoro N, Parasole R, Mann G, Karawajew L, Haas OA, Conter V, Schrappe M.
Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL.
Blood. 2017 Nov 9;130(19):2146-2149.

Longhi A, Bielack SS, Grimer R, Whelan J, Windhager R, Leithner A, Gronchi A, Biau D, Jutte P, Krieg AH, Klenke FM, Grignani G, Donati DM, Capanna R, Casanova J, Gerrand C, Bisogno G, Hecker-Nolting S, De Lisa M, D'Ambrosio L, Willegger M, Scoccianti G, Ferrari S.
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
Eur J Cancer. 2017 Mar;74:9-16.

Quidde J, Koch B,  Salchow J, Jensen W, von Grundherr J, Escherich G, Rutkowski S, Schulz-Kindermann F, Bergelt C, Bokemeyer C, Sokalska-Duhme M, Bielack S, Calaminus G,  Classen CF, Rössig C, Faber J, Faller H, Hilgendor I, Langer T, Metzler M, Schuster S, Niemeyer C, Pierce1 A, Reinhardt D, Dirksen U,  Sander A, Köhler M,  Stein A.
Survivorship – „Leben nach Krebs“-Programm: Versorgung von Patienten nach Krebserkrankung im Kindes-, Jugend- oder jungen Erwachsenenalter
Journal Onkologie 2017, 10/17:862-866, 2017

Quidde J, Koch B,  Salchow J, Jensen W, von Grundherr J, Escherich G, Rutkowski S, Schulz-Kindermann F, Bergelt C, Bokemeyer C, Sokalska-Duhme M, Bielack S, Calaminus G,  Classen CF, Rössig C, Faber J, Faller H, Hilgendor I, Langer T, Metzler M, Schuster S, Niemeyer C, Pierce1 A, Reinhardt D, Dirksen U,  Sander A, Köhler M,  Stein A.    
Das CARE-for-CAYA-Programm. Präventionskonzept für junge Menschen nach Krebserkrankung.
FORUM 2017, 32:479–484

Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Frühwald MC, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Körholz D, Koscielniak E, Kramm CM, Kuhlen M, Kulozik AE, Lamottke B, Leuschner I, Lohmann DR, Meinhardt A, Metzler M, Meyer LH, Moser O, Nathrath M, Niemeyer CM, Nustede R, Pajtler KW, Paret C, Rasche M, Reinhardt D, Rieß O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, von Schweinitz D, Simon T, Sparber-Sauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, von Bueren AO, Vorwerk P, Witt O, Wlodarski M, Wössmann W, Zenker M, Zimmermann S, Pfister SM, Kratz CP.
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
Am J Med Genet A. 2017 Apr;173(4):1017-1037.

Saloustros E, Stark DP, Michailidou K, Mountzios G, Brugieres L, Peccatori FA, Jezdic S, Essiaf S, Douillard JY, Bielack S.
The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey.
ESMO Open. 2017 Sep 8;2(4):e000252.

Smida J, Xu H, Zhang Y, Baumhoer D, Ribi S, Kovac M, von Luettichau I, Bielack S, O'Leary VB, Leib-Mösch C, Frishman D, Nathrath M.
Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma.
Int J Cancer. 2017 Aug 15;141(4):816-828.

Sparber-Sauer M, Seitz G, Kirsch S, Vokuhl C, Leuschner I, Dantonello TM, Scheer M, von Kalle T, Ljungman G, Bielack SS, Klingebiel T, Fuchs J, Koscielniak E; CWS Study Group.
The impact of local control in the treatment of type II/III pleuropulmonary blastoma. Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS).
J Surg Oncol. 2017 Feb;115(2):164-172.

Sparber-Sauer M, von Kalle T, Seitz G, Dantonello T, Scheer M, Münter M, Fuchs J, Ladenstein R, Bielack SS, Klingebiel T, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe (CWS).
The prognostic value of early radiographic response in children and adolescents with embryonal rhabdomyosarcoma stage IV, metastases confined to the lungs: A report from the Cooperative Weichteilsarkom Studiengruppe (CWS).
Pediatr Blood Cancer. 2017 Oct;64(10).

Stegmaier S, Leuschner I, Poremba C, Ladenstein R, Kazanowska B, Ljungman G, Scheer M, Blank B, Bielack S, Klingebiel T, Koscielniak E.
The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.
Pediatr Blood Cancer. 2017 Jan;64(1):89-95.

Grüner F, Loff S, von Kalle T, Bielack S.
Bauchumfangszunahme bei einer Jugendlichen. 
Monatsschr Kinderheilkd 2017

2016

Seitz G, Fuchs J, Martus P, Klingebiel T, Leuschner I, Schuck A, Dantonello TM, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe (CWS).
Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.
Ann Surg. 2016 Dec;264(6):1148-1155

Anderson PM, Bielack SS, Gorlick RG, Skubitz K, Daw NC, Herzog CE, Monge OR, Lassaletta A, Boldrini E, Pápai Z, Rubino J, Pathiraja K, Hille DA, Ayers M, Yao SL, Nebozhyn M, Lu B, Mauro D.
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.
Pediatr Blood Cancer. 2016 Oct;63(10):1761-70.

Bielack SS, Hecker-Nolting S, Blattmann C, Kager L.
Advances in the management of osteosarcoma.
F1000Res. 2016 Nov 25;5:2767. Review.

Bielack S, Kager L, Hecker-Nolting S, Blattmann C, Nathrath M, von Kalle T, Wirth T, Jürgens H.
Therapie von Kindern, Jugendlichen und jungen Erwachsenen mit Osteosarkom.
Journal Onkologie 2016

Bogen D, Brunner C, Walder D, Ziegler A, Abbasi R, Ladenstein RL, Noguera R, Martinsson T, Amann G, Schilling FH, Ussowicz M, Benesch M, Ambros PF, Ambros IM.
The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma.
Int J Cancer. 2016 Jul 1;139(1):153-63.

Escherich G, Bielack S, Maier S, Braungart R, Brümmendorf TH, Freund M, Grosse R, Hoferer A, Kampschulte R, Koch B, Lauten M, Milani V, Ross H, Schilling F, Wöhrle D, Cario H, Dirksen U.
Building a National Framework for Adolescent and Young Adult Hematology and Oncology and Transition from Pediatric to Adult Care: Report of the Inaugural Meeting of the "AjET" Working Group of the German Society for Pediatric Oncology and Hematology.
J Adolesc Young Adult Oncol. 2016 Dec 16.

Ferrari A, Dirksen U, Bielack S.
Sarcomas of Soft Tissue and Bone.
Prog Tumor Res. 2016;43:128-41.

Jaaks P, Meier G, Alijaj N, Brack E, Bode P, Koscielniak E, Wachtel M, Schäfer BW, Bernasconi M.
The proprotein convertase furin is required to maintain viability of alveolar rhabdomyosarcoma cells.
Oncotarget. 2016 Nov 22;7(47):76743-76755.

Kaatsch P, Strothotte J, Becker C, Bielack S, Dirksen U, Blettner M.
Pediatric bone tumors in Germany from 1987 to 2011: incidence rates, time trends and survival.
Acta Oncol. 2016 Sep-Oct;55(9-10):1145-1151.

Kager L, Whelan J, Dirksen U, Hassan B, Anninga J, Bennister L, Bovée JV, Brennan B, Broto JM, Brugières L, Cleton-Jansen AM, Copland C, Dutour A, Fagioli F, Ferrari S, Fiocco M, Fleuren E, Gaspar N, Gelderblom H, Gerrand C, Gerß J, Gonzato O, van der Graaf W, Hecker-Nolting S, Herrero-Martín D, Klco-Brosius S, Kovar H, Ladenstein R, Lancia C, LeDeley MC, McCabe MG, Metzler M, Myklebost O, Nathrath M, Picci P, Potratz J, Redini F, Richter GH, Reinke D, Rutkowski P, Scotlandi K, Strauss S, Thomas D, Tirado OM, Tirode F, Vassal G, Bielack SS.
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report.
Clin Sarcoma Res. 2016 Mar 16;6:3.

Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KL, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PC, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MC, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS.
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Lancet Oncol. 2016 Oct;17(10):1396-1408.

Satheesha S, Manzella G, Bovay A, Casanova EA, Bode PK, Belle R, Feuchtgruber S, Jaaks P, Dogan N, Koscielniak E, Schäfer BW.
Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma.
Oncogene. 2016 Apr 21;35(16):2020-30.

Scheer M, Dantonello T, Hallmen E, Blank B, Sparber-Sauer M, Vokuhl C, Leuschner I, Münter MW, von Kalle T, Bielack SS, Klingebiel T, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe [CWS].
Synovial Sarcoma Recurrence in Children and Young Adults.
Ann Surg Oncol. 2016 Dec;23(Suppl 5):618-626.

Scheer M, Dantonello T, Hallmen E, Vokuhl C, Leuschner I, Sparber-Sauer M, Kazanowska B, Niggli F, Ladenstein R, Bielack SS, Klingebiel T, Koscielniak E.
Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group.
Pediatr Blood Cancer. 2016 Jul;63(7):1198-206.

Seitz G, Fuchs J, Sparber-Sauer M, Leuschner I, Godzinski J, Klingebiel T, Schuck A, Martus P, Dantonello TM, Koscielniak E.
Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P Trial.
Ann Surg Oncol. 2016 Nov;23(12):4067-4072

Spix C, Berthold F, Hero B, Michaelis J, Schilling FH.
Correction factors for self-selection when evaluating screening programmes.
J Med Screen. 2016 Mar;23(1):44-9.

Thiel U, Wawer A, von Luettichau I, Bender HU, Blaeschke F, Grunewald TG, Steinborn M, Röper B, Bonig H, Klingebiel T, Bader P, Koscielniak E, Paulussen M, Dirksen U, Juergens H, Kolb HJ, Burdach SE.
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
Oncotarget. 2016 Oct 25;7(43):70959-70968.

Worst BC, van Tilburg CM, Balasubramanian GP, Fiesel P, Witt R, Freitag A, Boudalil M, Previti C, Wolf S, Schmidt S, Chotewutmontri S, Bewerunge-Hudler M, Schick M, Schlesner M, Hutter B, Taylor L, Borst T, Sutter C, Bartram CR, Milde T, Pfaff E, Kulozik AE, von Stackelberg A, Meisel R, Borkhardt A, Reinhardt D, Klusmann JH, Fleischhack G, Tippelt S, Dirksen U, Jürgens H, Kramm CM, von Bueren AO, Westermann F, Fischer M, Burkhardt B, Wößmann W, Nathrath M, Bielack SS, Frühwald MC, Fulda S, Klingebiel T, Koscielniak E, Schwab M, Tremmel R, Driever PH, Schulte JH, Brors B, von Deimling A, Lichter P, Eggert A, Capper D, Pfister SM, Jones DT, Witt O.
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
Eur J Cancer. 2016 Sep;65:91-101.

2015

Publikationen der Pädiatrie 5 sortiert nach IF (Impact factor, Stand 2015), Pädiatrie 5 Coautoren durch Fettdruck markiert.

Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. MAP plus maintenance pegylated interferon-2b (MAPifn) versus MAP alone in patients with resectable high grade osteosarcoma and good histological response to preoperative MAP: First results of the EURAMOS 1 Good Response randomized controlled trial. J Clin Oncol 33(20):2279-87, 2015
IF: 18.428

Isakoff M, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol 33:3029-35, 2015.
IF: 18.428

Kovac M, Blattmann C, Ribi S, Smida J, Mueller NS, Engert F, Castro-Giner F, Weischenfeldt J, Kovacova M, Krieg A, Andreou D, Tunn PU, Dürr HR, Rechl H, Schaser KD, Melcher I, Stefan E.G. Burdach, Kulozik A, Specht K, Heinimann K, Fulda S, Bielack S, Jundt G, Tomlinson I, Korbel JO, Nathrath M, Baumhoer D. Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. Nat Commun. 2015;6:8940
IF: 11.47

Cseh A, Niemeyer CM, Yoshimi A, Dworzak M, Hasle H, van den Heuvel-Eibrink MM, Locatelli F, Masetti R, Schmugge M, Groß-Wieltsch U, Candás A, Kulozik AE, Olcay L, Suttorp M, Furlan I, Strahm B, Flotho C. Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood. 2015 Apr 2;125(14):2311-3. doi: 10.1182/blood-2015-01-619734.
IF: 10.452

Thalhammer V, Lopez-Garcia LA, Herrero-Martin D, Hecker R, Laubscher D, Gierisch ME, Wachtel M, Bode P, Nanni P, Blank B, Koscielniak E, Schäfer BW. PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma. Cancer Res. 2015 Jan 1;75(1):98-110.
IF: 9.329

Satheesha S, Manzella G, Bovay A, Casanova EA, Bode PK, Belle R, Feuchtgruber S, Jaaks P, Dogan N, Koscielniak E, Schäfer BW. Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma. Oncogene. 2015 Jul 20. doi: 10.1038/onc.2015.267. [Epub ahead of print]
IF: 8.459

Seitz G, Fuchs J, Martus P, Klingebiel T, Leuschner I, Schuck A, Dantonello TM, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe (CWS). Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P. Ann Surg. 2015 Dec 31. [Epub ahead of print]
IF: 8.33

Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau C, Letson GD, Meyer J, Meyers P, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M; on behalf of the EURAMOS collaborators. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment. Ann Oncol. 2015 Feb;26(2):407-14.
IF: 7.04

Bode SF, Ammann S, Al-Herz W, Bataneant M, Dvorak CC, Gehring S, Gennery A, Gilmour KC, Gonzalez-Granado LI, Groß-Wieltsch U, Ifversen M, Lingman-Framme J, Matthes-Martin S, Mesters R, Meyts I, van Montfrans JM, Pachlopnik Schmid J, Pai SY, Soler-Palacin P, Schuermann U, Schuster V, Seidel MG, Speckmann C, Stepensky P, Sykora KW, Tesi B, Vraetz T, Waruiru C, Bryceson YT, Moshous D, Lehmberg K, Jordan MB, Ehl S; Inborn Errors Working Party of the EBMT. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica. 2015 Jul;100(7):978-88. doi: 10.3324/haematol.2014.121608. Epub 2015 May 28
IF: 5.814

Frezza AM, Cesari M, Baumhoer D, Biau D, Bielack S, Campanacci DA, Casanova J, Esler C, Ferrari S, Funovics PT, Gerrand C, Grimer R, Gronchi A, Haffner N, Hecker-Nolting S, Höller S, Jeys L, Jutte P, Leithner A, San-Julian M, Thorkildsen J, Vincenzi B, Windhager R, Whelan J. Mesenchymal chondrosarcoma: Prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. Eur J Cancer. 2015 Feb;51(3):374-81
IF: 5.417

Bogen D, Brunner C, Walder D, Ziegler A, Abbasi R, Ladenstein RL, Noguera R, Martinsson T, Amann G, Schilling FH, Ussowicz M, Benesch M, Ambros PF, Ambros IM. The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma. Int J Cancer. 2016 Feb 22. doi: 10.1002/ijc.30050. [Epub ahead of print
IF: 5.085

Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Müller I, Suttorp M, Bernig T, Beutel K, Bode SF, Kentouche K, Kolb R, Längler A, Minkov M, Schilling FH, Schmid I, Vieth S, Ehl S, Zur Stadt U, Janka GE. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. Br J Haematol. 2015 May 4. doi: 10.1111/bjh.13462. [Epub ahead of print]
IF: 4.711

Blattmann C, Oertel S, Thiemann M, Dittmar A, Roth E, Kulozik AE, Ehemann V, Weichert W, Huber PE, Stenzinger A, Debus J. Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy. Radiat Oncol. 2015 Jul 16;10:146. doi: 10.1186/s13014-015-0455-z.
IF: 4.363

Schlegel P, Feuchtinger T, Nitschke-Gérard C, Seidel UJ, Lang AM, Kyzirakos C, Teltschik HM, Ebinger M, Schumm M, Koscielniak E, Handgretinger R, Lang P. Favorable NK cell activity after haploidentical hematopoietic stem cell transplantation in stage IV relapsed Ewing's sarcoma patients. Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S72-6. doi: 10.1038/bmt.2015.100.
IF: 3.57

Spix C, Berthold F, Hero B, Michaelis J, Schilling FH. Correction factors for self-selection when evaluating screening programmes. J Med Screen. 23(1):44-9, 2016
IF: 3.099

Kager L, Diakos C, Bielack S. Can pharmacogenomics help to improve therapy in patients with high-grade osteosarcoma? Expert Opin Drug Metab Toxicol. 2015 Apr 16:1-4.
IF: 2.831

Scheer M, Dantonello T, Hallmen E, Vokuhl C, Leuschner I, Sparber-Sauer M, Kazanowska B, Niggli F, Ladenstein R, Bielack SS, Klingebiel T, Koscielniak E, on behalf of the Cooperative Weichteilsarkom Studiengruppe [CWS]. Primary metastatic synovial sarcoma – experience oft he CWS study group. Pediatr Blood Cancer 2016 [accepted for publication, PBC-15-1276.R1]
IF: 2.386

Dantonello TM, Stark M, Timmermann B, Fuchs J, Selle B, Linderkamp C, Handgretinger R, Hagen R, Feuchtgruber S, Kube S, Kosztyla D, Kazanowska B, Ladenstein R, Niggli F, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe [CWS]. Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma. Pediatr Blood Cancer. 2015 Jan;62(1):16-23
IF: 2.386

Oberlin O, Rey A, Brown KL, Bisogno G, Koscielniak E, Stevens MC, Hawkins DS, Meyer WH, La TH, Carli M, Anderson JR. Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups. Pediatr Blood Cancer. 2015 Dec;62(12):2125-31
IF: 2.386

Tamamyan G, Dominkus M, Lang S, Diakos C, Mittheisz E, Horcher E, Holter W, Zoubek A, Bielack S, Kager L. Multiple relapses in high-grade osteosarcoma: When to stop aggressive therapy? Pediatr Blood Cancer. 2015 Mar;62(3):529-30.
IF: 2.386

Stark D, Bielack S, Brugieres L, Dirksen U, Duarte X, Dunn S, Erdelyi DJ, Grew T, Hjorth L, Jazbec J, Kabickova E, Konsoulova A, Kowalczyk JR, Lassaletta A, Laurence V, Lewis I, Monrabal A, Morgan S, Mountzios G, Olsen PR, Renard M, Saeter G, van der Graaf WT, Ferrari A. Teenagers and Young Adults with Cancer in Europe: from national programs to an     European integrated coordinated project. Eur J Cancer Care (Engl). 2015 Aug 4. doi: 10.1111/ecc.12365. [Epub ahead of print]
IF: 1.564

Zils K, Klingebiel T, Behnisch W, Mueller HL, Schlegel PG, Fruehwald M, Suttorp M, Simon T, Werner M, Bielack S. Osteosarcoma in Patients with Rothmund-Thomson Syndrome. Pediatr Hematol Oncol. 2015 Feb;32(1):32-40.
IF: 1.096

Bielack SS, Hecker-Nolting S, Kevric M, Juergens H. More on Osteosarcoma and Phylloides Tumor. J Pediatr Hematol Oncol. 2015 Mar;37(2):158-9.
IF: 0.902

Zils K, Bielack S. Osteosarcoma after bone marrow transplantation: still a challenge. J Pediatr Hematol Oncol. 2015 Jan;37(1):74.
IF: 0.902

Leithner A, Andreou D, Grimer R, Ferrari S, Gosheger G, Papagelopoulos PJ, Bielack S. Conference report on the 28th annual meeting of the European Musculo-Skeletal Oncology Society, 29 April–1 May 2015, Athens. Ecancermedicalscience. 2015 Jul 8;9:550. doi: 10.3332/ecancer.2015.550. eCollection 2015
IF:---

2014

Anninga J, Cleton-Jansen AM, Hassan B, Amary MA, Baumhoer D, Blay JY, Brugieres L, Ferrari S, Jürgens J, Kempf-Bielack B, Kovar H, Myklebost O, Nathrath M, Picci P, Riegman P, Schilham MW, Soliman R, Stark DP, Strauss S, Sydes M, Tarpey P, Thomas D, Whelan J, Wilhelm M, Zamzam M, Gelderblom H, Bielack S.
Workshop report on the 2nd Joint ENCCA/EuroSARC European bone sarcoma network meeting: integration of clinical trials with tumour biology. Clinical Sarcoma Research 4:4, 2014, www.clinicalsarcomaresearch.com/content/4/1/42014

Bielack SS, Hecker-Nolting S, Kevric M, Juergens H.
More on Osteosarcoma and Phylloides Tumor. J Pediatr Hematol Oncol. 2014 Sep 26. [Epub ahead of print]

Bielack S, Kager L.
Multimodale Therapie des Osteosarkoms. Gesicherte Erkenntnisse und offene Fragen. JATROS Onkologie 2014; 3/14:136-139

Bielack S, Kevric M.
High BMI at diagnosis is not associated with inferior survival in patients with osteosarcoma. A report from the Cooperative Osteosarcoma Study Group. Pediatr Blood Cancer. 2014 May;61(5):952.

Bielack SS, Smeland S, Whelan J, et al.
MAP plus maintenance pegylated interferon-2b (MAPifn) versus MAP alone in patients with resectable high grade osteosarcoma and good histological response to preoperative MAP: First results of the EURAMOS 1 Good Response randomized controlled trial. J Clin Oncol 2015 [JCO/2014/600734, in press]

Brecht IB, Bremensdorfer C, Schneider DT, Frühwald MC, Offenmüller S, Mertens R, Vorwerk P, Koscielniak E, Bielack SS, Benesch M, Hero B, Graf N, von Schweinitz D, Kaatsch P.
Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001-2010. Pediatr Blood Cancer. 2014 Jul;61(7):1202-9.

Dantonello TM, Lochbühler H, Schuck A, Kube S, Godzinski J, Sköldenberg E, Ljungman G, Kosztyla D, Veit-Friedrich I, Hallmen E, Feuchtgruber S, Wessalowski R, Franke M, Bielack SS, Klingebiel T, Koscielniak E.
Challenges in the local treatment of large abdominal embryonal rhabdomyosarcoma. Ann Surg Oncol. 2014 Oct;21(11):3579-86.

Fuchs J, Dantonello TM, Blumenstock G, Kosztyla D, Klingebiel T, Leuschner I, Schuck A, Niggli FK, Koscielniak E, Seitz G.
Treatment and outcome of patients suffering from perineal/perianal rhabdomyosarcoma: results from the CWS trials--retrospective clinical study. Ann Surg. 2014 Jun;259(6):1166-72.

Hecker-Nolting S, Bielack S.
Therapie primär maligner Knochentumoren. Tumor Diagnostik & Therapie 2014; 35:472-475

Hospach T, Bielack S, v. Kalle T.
Nächtliche Schmerzen am Bewegungsapparat: Die Anamnese weist den Weg zur Diagnose. Kinderärztliche Praxis 2014; 85, 174 – 176

Kager L, Bielack S.
Chemotherapeutische Konzepte bei Knochensarkomen. Unfallchirurg. 2014 Jun;117(6):517-22.

Seeringer A, Bartelheim K, Kerl K, Hasselblatt M, Leuschner I, Rutkowski S, Timmermann B, Kortmann RD, Koscielniak E, Schneppenheim R, Warmuth-Metz M, Gerß J, Siebert R, Graf N, Boos J, Frühwald MC.
Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors - experience of the EU-RHAB registry. Klin Padiatr. 2014 May;226(3):143-8. doi: 10.1055/s-0034-1368719. Epub 2014 Mar 14.

Seitz G, Dantonello TM, Kosztyla D, Klingebiel T, Leuschner I, Fuchs J, Koscielniak E; Cooperative Soft Tissue Sarcoma Study Group.
Impact of hemiscrotectomy on outcome of patients with embryonal paratesticular rhabdomyosarcoma: results from the Cooperative Soft Tissue Sarcoma Group Studies CWS-86, 91, 96 and 2002P. J Urol. 2014 Sep;192(3):902-7. doi: 10.1016/j.juro.2014.03.005. Epub 2014 Mar 12.

Sorg B, Kevric M, Hecker-Nolting S, Kempf-Bielack B, Daniels K, Bielack S.
Osteosarkome. Onkologische Pflege 2014; 3:49-58, 2014

Streif W, Knöfler R, Eberl W, Andres O, Bakchoul T, Bergmann F, Beutel K, Dittmer R, Gehrisch S, Gottstein S, Halimeh S, Haselböck J, Hassenpflug WA, Heine S, Holzhauer S, King S, Kirchmaier CM, Krause M, Kreuz W, Lösche W, Mahnel R, Maurer M, Nimtz-Talaska A, Olivieri M, Rott H, Schambeck ChM, Schedel A, Schilling FH, Schmugge M, Schneppenheim R, Scholz U, Scholz T, Schulze H, Siegemund A, Strauß G, Sykora KW, Wermes C, Wiegering V, Wieland I, Zieger B, Zotz RB.
[Therapy of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.)]. Hamostaseologie. 2014;34(4):269-75

Tallen G, Bielack S, Henze G, Horneff G, Korinthenberg R, Lawrenz B, Niehues T, Peitz J, Placzek R, Schmittenbecher P, Schönau E, Wessel L, Wirth T, Mentzel HJ, Creutzig U.
Musculoskeletal pain: a new algorithm for differential diagnosis of a cardinal symptom in pediatrics. Klin Padiatr. 2014 Apr;226(2):86-98. 

Watzka M, Geisen C, Scheer M, Wieland R, Wiegering V, Dörner T, Laws HJ, Gümrük F, Hanalioglu S, Unal S, Albayrak D, Oldenburg J.
Bleeding and non-bleeding phenotypes in patients with GGCX gene mutations. Thromb Res. 2014 Oct;134(4):856-65.

Wilhelm M, Dirksen U, Bielack SS, Whelan JS, Lewis IJ, Jürgens H, Ferrari S, Sundby Hall K, Cleton-Jansen AM, Stark D.
ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas. Ann Oncol. 2014 Aug;25(8):1500-5.

2013

Benesch M, von Bueren AO, Dantonello T, von Hoff K, Pietsch T, Leuschner I, Claviez A, Bierbach U, Kropshofer G, Korinthenberg R, Graf N, Suttorp M, Kortmann RD, Friedrich C, von der Weid N, Kaatsch P, Klingebiel T, Koscielniak E, Rutkowski S:
Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groups. J Neurooncol. 2013 Feb;111(3):337-45. doi: 10.1007/s11060-012-1020-3. Epub 2012 Dec 11.

Bielack S, Kempf-Bielack B, Von Kalle T, Schwarz R, Wirth T, Kager L, Whelan J:
Controversies in childhood osteosarcoma. Minerva Pediatr. 2013 Apr;65(2):125-48.

Bielack S, Kevric M:
High BMI at diagnosis is not associated with inferior survival in patients with osteosarcoma. A report from the Cooperative Osteosarcoma Study Group. Pediatr Blood Cancer. 2013 Oct 11. doi: 10.1002/pbc.24817. [Epub ahead of print]

Blattmann C, Thiemann M, Stenzinger A, Christmann A, Roth E, Ehemann V, Debus J, Kulozik AE, Weichert W, Huber PE, Oertel S, Abdollahi A:
Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model. Strahlenther Onkol. 2013 Nov;189(11):957-66. doi: 10.1007/s00066-013-0372-8. Epub 2013 Jun 27.

Bochennek K, Dantonello T, Koscielniak E, Claviez A, Dirksen U, Sauerbrey A, Beilken A, Klingebiel T:
Response of children with stage IV soft tissue sarcoma to topotecan and carboplatin: a phase II window trial of the cooperative soft tissue sarcoma group. Klin Padiatr. 2013 Nov;225(6):309-14. doi: 10.1055/s-0033-1341489. Epub 2013 Aug 14.

Collins M, Wilhelm M, Conyers R, Herschtal A, Whelan J, Bielack S, Kager L, Kühne T, Sydes M, Gelderblom H, Ferrari S, Picci P, Smeland S, Eriksson M, Petrilli AS, Bleyer A, Thomas DM:
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. J Clin Oncol. 2013 Jun 20;31(18):2303-12. doi: 10.1200/JCO.2012.43.8598. Epub 2013 May 13.

Dantonello TM, Int-Veen C, Schuck A, Seitz G, Leuschner I, Nathrath M, Schlegel PG, Kontny U, Behnisch W, Veit-Friedrich I, Kube S, Hallmen E, Kazanowska B, Ladenstein R, Paulussen M, Ljungman G, Bielack S, Klingebiel T, Koscielniak E: Cooperative Weichteilsarkom Studiengruppe.Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma. Pediatr Blood Cancer. 2013 Aug;60(8):1267-73. doi: 10.1002/pbc.24488. Epub 2013 Feb 15.

Dantonello TM, Leuschner I, Vokuhl C, Gfroerer S, Schuck A, Kube S, Nathrath M, Bernbeck B, Kaatsch P, Pal N, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E; CWS: Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatr Blood Cancer. 2013 Feb;60(2):224-9. doi: 10.1002/pbc.24174. Epub 2012 Apr 25.

Fuchs J, Dantonello TM, Blumenstock G, Kosztyla D, Klingebiel T, Leuschner I, Schuck A, Niggli FK, Koscielniak E, Seitz G:
Treatment and Outcome of Patients Suffering From Perineal / Perianal Rhabdomyosarcoma: Results From the CWS Trials-Retrospective Clinical Study. Ann Surg. 2013 Sep 16. [Epub ahead of print]

Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, Ritterbusch H, Baumann U, Meyer-Bahlburg A, Witte T, Schmidt R, Borte M, Borte S, Linde R, Schubert R, Bienemann K, Laws HJ, Dueckers G, Roesler J, Rothoeft T, Krüger R, Scharbatke EC, Masjosthusmann K, Wasmuth JC, Moser O, Kaiser P, Groß-Wieltsch U, Classen CF, Horneff G, Reiser V, Binder N, El-Helou SM, Klein C, Grimbacher B, Kindle G:
The German national registry for primary immunodeficiencies (PID).
Clin Exp Immunol. 2013 Aug;173(2):372-80. doi: 10.1111/cei.12105.

Gothwal M, Nakamura L, Hainmann I, Koehler U, Schilling F, Rost S, Oldenburg J, Zieger B:
Molecular genetic analysis of a patient with moderate hemophilia A and psychomotor developmental delay. Klin Padiatr. 2013 May;225(3):175-6. doi: 10.1055/s-0033-1341490. Epub 2013 May 24

Kager L, Bielack S:
Biologie, Diagnostik, systemische und chirurgische Therapie. Osteosarkome. SPECTRUM ONKOLOGIE 2013, 3:30-33

Nitz A, Kontopantelis E, Bielack S, Koscielniak E, Klingebiel T, Langer T, Paulides M:
Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients. Oncol Lett. 2013 Jan;5(1):311-315. Epub 2012 Oct 25.

Rensing-Ehl A, Janda A, Lorenz MR, Gladstone BP, Fuchs I, Abinun M, Albert M, Butler K, Cant A, Cseh AM, Ebinger M, Goldacker S, Hambleton S, Hebart H, Houet L, Kentouche K, Kühnle I, Lehmberg K, Mejstrikova E, Niemeyer C, Minkov M, Neth O, Dückers G, Owens S, Rösler J, Schilling FH, Schuster V, Seidel MG, Smisek P, Sukova M, Svec P, Wiesel T, Gathmann B, Schwarz K, Vach W, Ehl S, Speckmann C:
Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia. Haematologica. 2013 Dec;98(12):1948-55. doi: 10.3324/haematol.2012.081901. Epub 2013 Jul 12

Rossig C, Juergens H, Schrappe M, Moericke A, Henze G, von Stackelberg A, Reinhardt D, Burkhardt B, Woessmann W, Zimmermann M, Gadner H, Mann G, Schellong G, Mauz-Koerholz C, Dirksen U, Bielack S, Berthold F, Graf N, Rutkowski S, Calaminus G, Kaatsch P, Creutzig U:
Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria. Pediatr Blood Cancer. 2013 Oct;60(10):1574-81. doi: 10.1002/pbc.24598. Epub 2013 Jun 5. Review.

Schäfer BW, Koscielniak E, Kovar H, Fulda S:
ESF-EMBO Symposium "Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence" Sept 29-Oct 4, Polonia Castle Pultusk, Poland. Front Oncol. 2013 Jun 4;3:142. doi: 10.3389/fonc.2013.00142. eCollection 2013.

Schultze-Florey RE, Graf N, Vorwerk P, Koscielniak E, Schneider DT, Kratz CP:
DICER1 syndrome: a new cancer syndrome. Klin Padiatr. 2013 May;225(3):177-8. doi: 10.1055/s-0033-1337976. Epub 2013 Apr 26.

Simon-Keller K, Paschen A, Hombach AA, Ströbel P, Coindre JM, Eichmüller SB, Vincent A, Gattenlöhner S, Hoppe F, Leuschner I, Stegmaier S, Koscielniak E, Leverkus M, Altieri DC, Abken H, Marx A:
Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholine receptor-redirected T cells. Am J Pathol. 2013 Jun;182(6):2121-31. doi: 10.1016/j.ajpath.2013.02.017. Epub 2013 Apr 2.

Thiel U, Koscielniak E, Blaeschke F, Grunewald TG, Badoglio M, Diaz MA, Paillard C, Prete A, Ussowicz M, Lang P, Fagioli F, Lutz P, Ehninger G, Schneider P, Santucci A, Bader P, Gruhn B, Faraci M, Antunovic P, Styczynski J, Krüger WH, Castagna L, Rohrlich P, Ouachée-Chardin M, Salmon A, Peters C, Bregni M, Burdach S; Solid Tumour Working Party and the Paediatric Disease Working Party of the European Group for Blood and Marrow Transplantation:
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment. Br J Cancer. 2013 Nov 12;109(10):2523-32. doi: 10.1038/bjc.2013.630. Epub 2013 Oct 22.

Wilhelm M, Bielack S, Zils K, Gosheger G, Friedel G, Lehner B, von Kalle T:
Primary Pulmonary Metastatic Osteosarcoma: To Stop or Not to Stop, That is the Question JAYAO 2013, 2: 38-41

Zils K, Bielack S:
Osteosarcoma After Bone Marrow Transplantation: Still a Challenge. J Pediatr Hematol Oncol. 2013 Aug 7. [Epub ahead of print]

Zils K, Bielack S, Wilhelm M, Werner M, Schwarz R, Windhager R, Hofmann-Wackersreuther G, Andus T, Kager L, Kuehne T, Reichardt P, von Kalle T:
Osteosarcoma of the mobile spine. Ann Oncol. 2013 Aug;24(8):2190-5. doi: 10.1093/annonc/mdt154. Epub 2013 Apr 23.

Zils K, Wirth T, Loff S, Biskup S, von Kalle T, Bielack S:
Multiple Metachronous Osteosarcomas in a Patient with Li-Fraumeni Syndrome. Pediatr Hematol Oncol. 2013 Nov 25. [Epub ahead of print]

2012

Zernikow B, Bürk B, Gerhold K, Häuser W, Hospach T, Illhardt A, Mönkemöller K, Richter M, Schnöbel-Möller R, Häfner R:
Definition, Diagnostik und Therapie von chronischen Schmerzen in mehreren Körperregionen und des sogenannten Fibromyalgiesyndroms bei Kindern und Jugendlichen. AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V.) Leitlinie 2012, im Druck

Stegmaier S, Bielack S, Leuschner I, Klingebiel T, Koscielniak E:
Questionable Universal Validity of PAX3/FOXO1 Fusion Gene Status as Molecular Marker for Improvement of Risk Stratification in Rhabdomyosarcoma Therapy. J Clin Oncol 2012; 30:4039-4040

Collins M, Wilhelm M, Conyers R, Herschtal A, Whelan J, Bielack S, Kager L, Kühne T, Sydes M, Gelderblom H, Ferrari S, Picci P, Smeland S, Eriksson M, Petrilli S, Bleyer A, Thomas DM:
Benefits and adverse events in younger versus older patients receiving (neo)-adjuvant chemotherapy for osteosarcoma: findings from a 4,403 patient meta-analysis. J Clin Oncol manuscript #JCO/2012/438598, accepted for publication 08.11.12

Dantonello TM, Leuschner I, Vokuhl C, Gfroerer S, Schuck A, Kube S, Nathrath M, Bernbeck B, Kaatsch P, Pal N, Ljungman G, Bielack S, Klingebiel T, Koscielniak E; on behalf of CWS:
Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe.
Pediatr Blood Cancer 2013; 60:224-229 (2012 Apr 25. doi:
10.1002/pbc.24174., [Epub ahead of print]

Jones DT, Jäger N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stütz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, Pleier S, Cin H, Pfaff E, Sieber L, Wittmann A, Remke M, Witt H, Hutter S, Tzaridis T, Weischenfeldt J, Raeder B, Avci M, Amstislavskiy V, Zapatka M, Weber UD, Wang Q, Lasitschka B, Bartholomae CC, Schmidt M, von Kalle C, Ast V, Lawerenz C, Eils J, Kabbe R, Benes V, van Sluis P, Koster J, Volckmann R, Shih D, Betts MJ, Russell RB, Coco S, Tonini GP, Schüller U, Hans V, Graf N, Kim YJ, Monoranu C, Roggendorf W, Unterberg A, Herold-Mende C, Milde T, Kulozik AE, von Deimling A, Witt O, Maass E, Rössler J, Ebinger M, Schuhmann MU, Frühwald MC, Hasselblatt M, Jabado N, Rutkowski S, von Bueren AO, Williamson D, Clifford SC, McCabe MG, Collins VP, Wolf S, Wiemann S, Lehrach H, Brors B, Scheurlen W, Felsberg J, Reifenberger G, Northcott PA, Taylor MD, Meyerson M, Pomeroy SL, Yaspo ML, Korbel JO, Korshunov A, Eils R, Pfister SM, Lichter P:
Dissecting the genomic complexity underlying medulloblastoma. Nature 2012; 488(7409):100-5

Bielack S:
Comment on 'Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?' Br J Cancer 2012; 107(3):583

Bielack S, Müller M, Andus T:
Transplantation: Ökonomische Zielvereinbarungen längst üblich. Deutsches Ärzteblatt 2012; 41:B1666

Thomas DM, Wilhelm M, Cleton-Jansen AM, Dirksen U, Entz-Werlé N, Gelderblom H,  Hassan B, Jürgens H, Koster J, Kovar H, Lankester AC, Lewis IJ, Myklebost O, Nathrath MHM, Picci P, Whelan JS, Hogendoorn PCW, Bielack S:
Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor Biology. Journal of Adolescent and Young Adult Oncology 2011; 1:118-123 (trotz Datumsangabe 2011 erst 2012 erschienen)

Wilhelm M, Hirsch W, Merkenschlager A, Stepan H, Geyer C, Kiess W:
A Rare Case of Congenital Choroid Plexus Carcinoma. Pediatr Hematol Oncol. 2012 Oct; 29(7):643-6

Zils K, Ebner F, Ott M, Müller J, Baumhoer D, Greulich M, Rehnitz D, Rempen A, Schaetzle S, Wilhelm M, Bielack S:
Extraskeletal osteosarcoma of the breast in an adolescent girl. J Pediatr Hematol Oncol 2012; 34:e261-e263

Zils K, Wilhelm M, Reeh T, Bielack S:
Bullous variant of acral erythema in a child after high-dose methotrexate. Pediatr Hematol Oncol 2012; 29:378-9

Enninger A:
Bakterielle Dünndarmfehlbesiedelung bei Kindern – eine nicht sehr häufige, aber häufig vergessene Differenzialdiagnose. Kinder- und Jugendarzt, 43. Jg, Nr. 10

Enninger A, Razeghi S:
Diagnostik und Therapie der Obstipation Umsetzung der aktuellen Leitlinien in der Praxis des Kinder- und Jugendarztes. Kinder- und Jugendarzt, 43. Jg, Nr. 3

Bielack S, Morland B, Mayor S:
Recent trials in osteosarcoma and their implications for future studies. Cancerworld May/June 2012, 13-20

Amrhein P, Hospach A, Sittel C, Koitschev A:
Acute otitis media in children: Antibiotic therapy or watchful waiting? HNO 2012 Dec 19

Baumhoer D, Elsner M, Smida J, Zillmer S, Rauser S, Schoene C, Balluff B, Bielack S, Jundt G, Walch A, Nathrath M:
CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients. Oncotarget 2012; 2:970-975

Benesch M, Wardelmann E, Leuschner I, Koscielniak E:
Gastrointestinale Stromatumoren im Kindes- und Jugendalter. Monatsschr Kinderheilkd 2012; 160:967–974

Garcia Segarra N, Mittaz L, Campos-Xavier AB, Bartels CF, Tuysuz B, Alanay Y, Cimaz R, Cormier-Daire V, Di Rocco M, Duba HC, Elcioglu NH, Forzano F, Hospach T, Kilic E, Kuemmerle-Deschner JB, Mortier G, Mrusek S, Nampoothiri S, Obersztyn E, Pauli RM, Selicorni A, Tenconi R, Unger S, Utine GE, Wright M, Zabel B, Warman ML, Superti-Furga A, Bonafé L:
The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): a review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals. Am J Med Genet C Semin Med Genet. 2012 Aug 15; 160C(3):217-29

Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, Boztug K, Pfeifer D, Kreipe H, Pfister ED, Baumann U, Puchalka J, Bohne J, Egritas O, Dalgic B, Kolho KL, Sauerbrey A, Buderus S, Güngör T, Enninger A, Koda YK, Guariso G, Weiss B, Corbacioglu S, Socha P, Uslu N, Metin A, Wahbeh GT, Husain K, Ramadan D, Al-Herz W, Grimbacher B, Sauer M, Sykora KW, Koletzko S, Klein C: Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 2012 Aug; 143(2):347-55

Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, Al-Jefri A, Beier R, Bomme Ousager L, Ehlert K, Gross-Wieltsch U, Jorch N, Kremens B, Pekrun A, Sparber-Sauer M, Mejstrikova E, Wawer A, Ehl S, zur Stadt U, Janka G:
Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood 2012 Jun 21; 119(25):6016-24

Pauli RM, Selicorni A, Tenconi R, Unger S, Utine GE, Wright M, Zabel B, Warman ML, Superti-Furga A, Bonafé L. Garcia Segarra N, Mittaz L, Campos-Xavier AB, Bartels CF, Tuysuz B, Alanay Y, Cimaz R, Cormier-Daire V, Di Rocco M, Duba HC, Elcioglu NH, Forzano F, Hospach T, Kilic E, Kuemmerle-Deschner JB, Mortier G, Mrusek S, Nampoothiri S, Obersztyn E:
The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): a review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals. Am J Med Genet C Semin Med Genet 2012; 160C:217-29

Rettinger E, Meyer V, Kreyenberg H, Volk A, Kuçi S, Willasch A, Koscielniak E, Fulda S, Wels WS, Boenig H, Klingebiel T, Bader P:
Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models. Front Oncol. 2012; 2:32

Rosales A, Hofer J, Zimmerhackl LB, Jungraithmayr TC, Riedl M, Giner T, Strasak A, Orth-Höller D, Würzner R, Karch H; German-Austrian HUS Study Group Collaborators:
Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis 2012; 54:1413-21

Ronceray L, Pötschger U, Janka G, Gadner H, Minkov M; German Society for Pediatric Hematology and Oncology, Langerhans Cell Histiocytosis Study Group (Dornbirn A, Ausserer B, Urban C, Meister B, Kaulfersch W, Kerbl R, Schmidt K, Sperl W, Gadner H, Van Gool S, Frühwald M, Schweigerer L, Henze G, Otte J, Dilloo D, Eberl W, Pekrun A, Scholbach T, Erler T, Paulussen M, Schneider D, Suttorp M, Borkhardt A, Sauerbrey A, Holter W, Eggert A, Klingebiel T, Niemeyer C, Reiter A, Lakomek M, Lode H, Körholz D, Janka G, Reinhardt D, Witt O, Längler A, Graf N, Beck JF, Nathrath M, Schrappe M, Nüßlein T, Berthold F, Niehues T, Christiansen H, Herting E, Vorwerk P, Faber J, Dürken M, Zimmer KP, Burdach S, Klein C, Jürgens H, Scheurlen W, Müller H, Corbacioglu S, Wigger M, Bielack S, Rauh W, Handgretinger R, Debatin K-, Schlegel PG, Kühne T, Leibundgut K, Ozsahin H, Beck-Popovic M, Neuhaus T, Niggli F, Kinderziekenhuis E, van den Bos C, Kamps WA, Bökkering JP, Pieters R):
Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome. J Pediatr 2012; 161(1):129-33

Siepermann M, Koscielniak E, Dantonello T, Klee D, Boos J, Krefeld B, Borkhardt A, Hoehn T, Asea A, Wessalowski R:
Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy. Pediatr Blood Cancer 2012; 58(1):104-6

Simon T, Niemann CA, Hero B, Henze G, Suttorp M, Schilling FH, Berthold F:
Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastoma. Dev Med Child Neurol. 2012 Apr; 54(4):347-52

Thiel U, Wolf P, Wawer A, Blaeschke F, Grunewald TG, von Lüttichau IT, Klingebiel T, Bader P, Borkhardt A, Laws HJ, Handgretinger R, Lang P, Schlegel PG, Eyrich M, Gruhn B, Ehninger G, Koscielniak E, Klein C, Sykora KW, Holler E, Mauz-Körholz C, Woessmann W, Richter GH, Schmidt AH, Peters C, Dirksen U, Jürgens H, Bregni M, Burdach S:
Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma. Klin Padiatr. 2012 Oct; 224(6):353-8

Zernikow B, Gerhold K, Bürk G, Häuser W, Hinze CH, Hospach T, Illhardt A, Mönkemöller K, Richter M, Schnöbel-Müller E, Häfner R:
Definition, Diagnostik und Therapie von chronischen Schmerzen in mehreren Körperregionen und des sogenannten Fibromyalgiesyndroms bei Kindern und Jugendlichen. Schmerz 2012 Jun; 26(3):318-30

2011

Andreou D, Bielack S, Carrle D, Kevric M, Kotz R, Winkelmann W, Jundt G, Werner M, Fehlberg S, Kager L, Kühne T, Lang S, Dominkus M, Exner GU, Hardes J, Hillmann A,  Ewerbeck V, Heise U, Reichardt P, Tunn PU:
The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Ann Oncol 22: 1228-1235, 2011

Armeanu-Ebinger S, Bonin M, Häbig K, Poremba C, Koscielniak E, Godzinski J, Warmann SW, Fuchs J, Seitz G:
Differential expression of invasion promoting genes in childhood rhabdomyosarcoma. Int J Oncol. 2011 Apr;38(4):993-1000

Aubin S, Barr R, Rogers P, Schacter B, Bielack S, Ferrari A, Manchester RA, McMaster K, Morgan S, Patterson M, Petrilli AS, Ribera JM, Shaw P, Thomas DM, Treadgold C:
Controversies: What Should the Age Range Be for AYA Oncology? Journal of Adolescent and Young Adult Oncology, 1: 3-10, 2011

Baumhoer D, Elsner M, Smida J, Zillmer S, Rauser S, Schoene C, Balluff B, Bielack S, Jundt G, Walch A, Nathrath M:
CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients. Oncotarget. 2011 Dec 24. [Epub ahead of print]

Baumhoer D, Smida J, Specht K, Bink K, Quintanilla-Martinez L, Rosemann M, Siggelkow H, Nathrath WB, Atkinson MJ, Bielack S, Jundt G, Nathrath M:
Aberrant expression of the HER-2 oncogene is not a common feature in osteosarcoma. Hum Pathol. 42:859-66, 2011

Benesch M, Leuschner I, Wardelmann E, Thielen M, Schmid I, Kontny U, Ebetsberger G, Frey E, Graf N, Schneider DT, Kremens B, Amann G, Urban C, Schlemmer M, Quehenberger F, Klingebiel T, Dantonello T, Koscielniak E:
Gastrointestinal stromal tumours in children and young adults: a clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS). Eur J Cancer. 2011 Jul;47(11):1692-8

Bielack S: JSCO University 12:
Bone, soft tissue, and skin cancers: Year in review in Europe – Bone sarcomas from a pediatric perspective. The Journal of Japan Society of Clinical Oncology 46(3):1402-1406, 2011

Bielack S, Marina N, Bernstein M:
High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomas. Cancer 117:2822, 2011 (letter)

Ellegast J, Barth TFE, Schulte M, Bielack S, Schmid M, Mayer-Steinacker R:
Diagnosis in Oncology: Metastasis of osteosarcoma after 16 years. J Clin Oncol 29(3):e62-6; 2011

Enninger A:
Diätempfehlungen bei Magen-Darm-Krankheiten – Was ist wirklich sinnvoll? pädiatrie hautnah 23 (S1): S50-S54

Enninger A:
Ess-, Fütter- und Schluckstörungen – Organische Ursachen ausschließen. pädiatrie hautnah 23 (6): 465–467, 2011

Enninger A:
Die EHEC-Epidemie – was ist neu, was ist anders? praxisfieber 2/11: 15; 2011

Enninger A:
Pädiatrisches Expertenmeeting Ernährung als Therapie. Teilnahme und Veröffentlichung 2011

Dantonello TM, Winkler P, Boelling T, Friedel G, Schmid I, Mattke AC, Ljungman G, Bielack S, Klingebiel T, Koscielniak E; on behalf of the CWS Study Group:
Embryonal Rhabdomyosarcoma With Metastases Confined To The Lungs: Report from the CWS Study Group. Pediatr Blood Cancer 56: 725-732, 2011

Franke, M, Hardes J, Helmke K, Jundt G, Jürgens H, Kempf-Bielack B, Kevric M, Tunn PU, Werner M, Bielack S:
Solitary Skeletal Osteosarcoma Recurrence. Findings From The Cooperative Osteosarcoma Study Group (COSS) Pediatr Blood Cancer 56:771–776, 2011

Jessen B, Maul-Pavicic A, Ufheil H, Vraetz T, Enders A, Lehmberg K, Längler A, Gross-Wieltsch U, Bay A, Kaya Z, Bryceson YT, Koscielniak E, Badawy S, Davies G, Hufnagel M, Schmitt-Graeff A, Aichele P, Zur Stadt U, Schwarz K, Ehl S:
Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. Blood. 2011 Oct 27;118(17):4620-9

Haufe S, Haug M, Schepp C, Kuemmerle-Deschner J, Hansmann S, Rieber N, Tzaribachev N, Hospach T, Maier J, Dannecker GE, Holzer U:
Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells. Arthritis Rheum. 2011 Oct;63(10):3153-62. doi: 10.1002/art.30503

Hess S, Hospach T, Nossal R, Dannecker G, Magdorf K, Uhlemann F:
Life-threatening disseminated tuberculosis as a complication of TNF-? blockade in an adolescent. Eur J Pediatr. 2011 Oct;170(10):1337-42. Epub 2011 May 31

Horneff G, Foeldvari I, Minden K, Moebius D, Hospach T:
Report on malignancies in the German juvenile idiopathic arthritis registry. Rheumatology (Oxford). 2011 Jan;50(1):230-6

Hospach T, Huppertz HI:
Kindliche Vaskulitis Purpura Schönlein Henoch. Z Rheumatol. 2011 Dec;70(10):829-37

Hospach T, Langendörfer M, Kalle TV, Tewald F, Wirth T, Dannecker GE:
Mimicry of lyme arthritis by synovial hemangioma. Rheumatol Int. 2011 Dec; 31(12):1639-43

Kager L, Bielack S:
Mifarmutid (Mepact). Internistische Praxis 51(4):899-901, 2011

Paulides M, Stöhr W, Laws HJ, Graf N, Lakomek M, Berthold F, Schmitt K, Niggli F, Jürgens H, Bielack S, Koscielniak E, Klingebiel T, Langer T:
Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: A report from the Late Effects Surveillance System. Vaccine 29:1565-1568, 2011

Ritter J, Zils K, Bielack S:
Osteosarkome bei Kindern und Jugendlichen. Pädiatrie up2date 6(1): 79-104, 2011

Schlegel P, Teltschik HM, Pfeiffer M, Handgretinger R, Schumm M, Koscielniak E, Feuchtinger T, Klingebiel T, Bader P, Schlegel PG, Greil J, Lang P:
Long-term IL-2 therapy after transplantation of T cell depleted stem cells from     alternative donors in children. Best Pract Res Clin Haematol. 2011 Sep;24(3):443-52

Seitz G, Dantonello TM, Int-Veen C, Blumenstock G, Godzinski J, Klingebiel T, Schuck A, Leuschner I, Koscielniak E, Fuchs J; CWS-96 Study Group:
Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96. Pediatr Blood Cancer. 2011 May;56(5):718-24

Siepermann M, Koscielniak E, Dantonello T, Klee D, Boos J, Krefeld B, Borkhardt A, Hoehn T, Asea A, Wessalowski R:
Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy. Pediatr Blood Cancer. 2012 Jan;58(1):104-6. doi: 10.1002/pbc.22934. Epub 2011 Jan 16

Stegmaier S, Poremba C, Schaefer KL, Leuschner I, Kazanowska B, Békássy AN, Bielack S, Klingebiel T, Koscielniak E:
Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: A report from the cooperative soft tissue sarcoma study group (CWS). Pediatr Blood Cancer. 57(3):406-14, 2011

Stahl M, Ranft A, Paulussen M, Bölling T, Vieth V, Bielack S, Görtitz I, Braun-Munzinger G, Hardes J, Jürgens H, Dirksen U:
Risk of Recurrence and Survival After Relapse in Patients with Ewing Sarcoma. Pediatr Blood Cancer 57:549-53, 2011

Thiel U, Wawer A, Wolf P, Badoglio M, Santucci A, Klingebiel T, Basu O, Borkhardt A, Laws HJ, Kodera Y, Yoshimi A, Peters C, Ladenstein R, Pession A, Prete A, Urban EC, Schwinger W, Bordigoni P, Salmon A, Diaz MA, Afanasyev B, Lisukov I, Morozova E, Toren A, Bielorai B, Korsakas J, Fagioli F, Caselli D, Ehninger G, Gruhn B, Dirksen U, Abdel-Rahman F, Aglietta M, Mastrodicasa E, Torrent M, Corradini P, Demeocq F, Dini G, Dreger P, Eyrich M, Gozdzik J, Guilhot F, Holler E, Koscielniak E, Messina C, Nachbaur D, Sabbatini R, Oldani E, Ottinger H, Ozsahin H, Schots R, Siena S, Stein J, Sufliarska S, Unal A, Ussowicz M, Schneider P, Woessmann W, Jürgens H, Bregni M, Burdach S;
Solid Tumor Working Party (STWP) and the Pediatric DiseaseWorking Party (PDWP) of the European Group for Blood and Marrow Transplantation (EBMT); Asia Pacific Blood and Marrow Transplantation (APBMT); Pediatric Registry for Stem Cell Transplantations (PRST); MetaEICESS Study Group: No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol. 2011 Jul;22(7):1614-21

Walter D, Satheesha S, Albrecht P, Bornhauser BC, D'Alessandro V, Oesch SM, Rehrauer H, Leuschner I, Koscielniak E, Gengler C, Moch H, Bernasconi M, Niggli FK, Schäfer BW; CWS Study Group:
CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. PLoS One. 2011;6(5):e19506. Epub 2011 May 13

Zils K, Bielack S:
Therapeutic management of osteosarcoma. Hospital Pharmacy Europe 56:51-54, 2011

BÜCHERBEITRÄGE

Bielack S, Dürr HR, Willich N:
Osteosarkom. pp 163-169 in: Schlag PM, Bamberg M, Jäger D (Hrsg.): Interdisziplinäre Entscheidungswege in der Onkologie. Diagnose- und Therapiealgorithmen mit Erläuterungen. Deutscher Ärzte-Verlag, Köln, 2011

Bielack S:
Osteosarkome. Kapitel L2 in: Wirth S, Böhles H, Creutzig U, Höger P, Kiess W, Krauspe R, Niehues T, Poets CF, Querfeld U, Schmittenbecher P, Trollmann R, Weil J, Weiß M, Zimmer K.-P. (Hrsg): Deutsche Gesellschaft für Kinder- und Jugendmedizin e.V.: Leitlinien Kinder- und Jugendmedizin, Lieferung 22. Elsevier, Urban & Fischer Verlag, München, Juni 2011

Gorlick R, Bielack S, Teot L, Meyer J, Randall RL, Marina N:
Osteosarcoma: Biology, Diagnosis, Treatment, and remaining challenges. pp 1015-1044 in: Pizzo PA, Poplack DG: Principles and practice of pediatric oncology, 6th edition. Wolters Kluwer, Lippincott Williams & Wilkins, Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokio, 2011

Hospach T, Klaus G:
Die Purpura Schönlein-Henoch. Aktualisierte Leitlinien Kinder- und Jugendmedizin. Hrg. T. Niehues, Elsevier, Urban & Fischer Verlag im Druck
Koscielniak E, Fuchs J, Leuschner I, Greulich M, Klingebiel T: Weichteiltumoren. pp 195-231 in. Fuchs J. Solide Tumoren im Kindesalter, 11. Ausg., Schattauer, Stuttgart

Paulussen M, Bielack S, Kovar H, Jürgens H, Bernstein ML:
Bone tumours. Chapter 22 in: Stevens MCG, Caron HN, Andrea Biondi A (eds.): Cancer in Children: Clinical Management. Sixth Edition. Oxford University Press, Oxford, 22 December 2011

2010

Whelan J, Patterson D, Perisoglou M, Bielack S, Marina N, Smeland S, Bernstein, M:
The Role of Interferons in the Treatment of Osteosarcoma. Pediatric Blood & Cancer 2010; 54: 350-354

Kager L, Zoubek A, Dominkus M, Lang S,Bodmer N, Jundt G, Klingebiel T, Jürgens H, Gadner H, Bielack S:
Osteosarcoma in very young children. Experience of the Cooperative Osteosarcoma Study Group. Cancer 2010 (in press)

Bielack S, Franke M:
Re: Wasilewski-Masker et al.: Late Recurrence in Pediatric Cancer: A Report From the Childhood Cancer Survivor Study. (J Natl Cancer Inst 2009;101:1–12)" J Natl Cancer Inst 2010 (letter, in press)

Grunewald TGP, von Luettichau I, Weirich G, Wawer A,Behrends U, Prodinger PM, Jundt G, Bielack S, Gradinger R, Burdach S:
Sclerosing Epithelioid Fibrosarcoma of the bone: a case report of high resistance to chemotherapy and a survey of the literature. Sarcoma 2010 (in press)

Bielack S, Carrle D, Friedel G:
Letter to Ibukuro et al. (AJR Am J Roentgenol. 2009; 193:W430-6)
AJR Am J Roentgenol. 2010 DOI:10.2214/AJR.09.3887

Kager L, Kempf-Bielack B, Bielack S:
Synchronous and Metachronous Lung Metastases in High-grade Osteosarcoma (letter). Jpn J Clin Oncol 40(1):94-5, 2010

Marina, M, Gorlick R, Bielack S:
Pediatric osteosarcoma. pp 383-394 in: Carrol WL and Finlay JL (eds.): Cancer in Children and adolescents. Jones and Bartlett Publishers, Sudbury, MA, 2010

Ritter J, Gosheger G, Bielack S:
Osteosarkome. pp1351-1371 in: Hiddemann W, Bartram CR (Hrsg.): Die Onkologie (2. Aufl.). Springer Medizin Verlag Heidelberg, 2010 (ISBN 978-3-540-79724-1)

Bielack S:
Editorial Comment - Osteosarcoma: Time to move on? Eur J Cancer 2010 (in press)

Gattenlöhner S, Jörißen H, Huhn M, Vincent A, Beeson D, Tzartos S, Mamalaki A, Etschmann B, Muller-Hermelink HK, Koscielniak E, Barth S, Marx A:
A Human Recombinant Autoantibody-Based Immunotoxin Specific for the Fetal Acetylcholine Receptor Inhibits Rhabdomyosarcoma Growth In Vitro and in a Murine Transplantation Model. J Biomed Biotechnol. 2010; 2010:187621. Epub 2010 Feb 24. PMID: 20204062

2009

N. Jaffe, Ø.S. Bruland, S. Bielack (Eds.):
Pediatric and Adolescent Osteosarcoma. Cancer Treatment and Research, Vol. 152 2009; Springer, Heidelberg, ISBN 978-1-4419-0283-2

Weber G, Karbach J, Kuçi S, Kreyenberg H, Willasch A, Koscielniak E, Tonn T, Klingebiel T, Wels WS, Jäger E, Bader P:
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation. Leukemia. 2009 Sept; 23(9): 1634-1642; Epub 2009 Apr 9

Theissen J, Boensch M, Spitz R, Betts D, Stegmaier S, Christiansen H, Niggli F, Schilling F, Schwab M, Simon T, Westermann F, Berthold F, Hero B:
Heterogeneity of the MYCN oncogene in neuroblastoma. Clin Cancer Res. 2009 Mar 15; 15(6): 2085-2090

Bielack S, Carrle D, Casali PG on behalf of the ESMO Guidelines Working Group:
Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20 (Supplement 4): iv137–iv139

Paulussen M, Bielack S, Jürgens H,  Casali GP on behalf of the ESMO Guidelines Working Group:
Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20: iv140-iv142

Dantonello TM, Int-Veen C, Harm Ds, Leuschner I, Schmidt BF, Herbst M, Juergens H, Scheel-Walter HG, Bielack SS, Klingebiel T, Dickerhoff R, Kirsch S, Brecht B, Schmel-zle R, Greulich M, Gadner H, Greiner J, Marky I, Treuner J, Koscielniak E:
Cooperative Trial CWS-91 for Localized Soft Tissue Sarcoma in Children, Adolescents, and Young Adults. J Clin Oncol 2009; 27(9): 1446-1455

Mattke AC, Bailey EJ, Schuck A, Dantonello T, Leuschner I, Klingebiel T, Treuner J, Koscielniak E:
Does the time-point of relapse influence outcome in pediatric rhabdom-yosarcomas? Pediatr Blood Cancer. 2009 Jul; 52(7): 772-776

Brecht IB , Graf N, von Schweinitz D ,Frühwald M , Bielack S, Schneider DT:
Networking for Children and Adolescents with Very Rare Tumors: Foundation of the GPOH Pediatric Rare Tumor Group [Ein Netzwerk für Kinder und Jugendliche mit besonders seltenen Tumoren: Gründung der GPOH Arbeitsgruppe für Seltene Tumoren.] Klin Padiatr 2009; 221: 181-185

Heinsohn S, Szendroi M, Bielack S, Zur Stadt U, Kabisch H:
Evaluation of SV40 in os-teosarcoma and healthy population: A Hungarian-German study. Oncology Rep 2009; 21(2): 289-297

Bielack S, Kempf-Bielack B, Branscheid D, Carrle D, Friedel G, Helmke K, Kevric M, Jundt G, Kühne T, Maas R, Schwarz R, Zoubek A, Jürgens H:
Second and subsequent recurrences of osteosarcoma: Presentation, treatment, and outcomes of 249 consecutive Cooperative Osteosarcoma Study Group (COSS) patients. J Clin Oncol 2009; 27: 557-565

Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S:
The role of radiotherapy in osteosarcoma. Cancer Treat Res 2009; 152: 147-165

Carrle D, Bielack S:
Osteosarcoma lung metastases detection and principles of multimodal therapy. Cancer Treat Res 2009; 152: 165-184

Bielack S, Jürgens H, Jundt G, Kevric M, Kühne T, Reichardt P, Zoubek A, Werner M, Winkelmann W, Kotz R:
Osteosarcoma: The COSS Experience. Cancer Treat Res 2009; 152: 289-308

Marina N, Bielack S, Whelan J, Smeland S, Krailo M, Sydes MR, Butterfass-Bahloul T, Calaminus G, Bernstein M:
International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience. Cancer Treat Res 2009; 152: 339-354

Kirsch S, Zirn C, Holder M, Leichter E, Calaminus G, Bielack S:
Pseudopubertas praecox: Isoliertes Symptom eines Keimzelltumors des zentralen Nervensystems. Monatsschr Kinderheilkd 2009; 157: 595-598

Dantonello TM, Int-Veen C, Harms D, Leuschner I, Schmidt BF, Herbst M, Juergens H, Scheel-Walter HG, Bielack SS, Klingebiel T, Dickerhoff R, Kirsch S, Brecht I, Schmelzle R, Greulich M, Gadner H, Greiner J, Marky I, Treuner J, Koscielniak E:
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol. 2009 Mar 20; 27(9): 1446-55. Epub 2009 Feb 17. PMID: 19224858

T. Hospach, P. v.d. Driesch, G.E. Dannecker:
Acute febrile neutrophilic dermatosis (Sweet`s syndrome) in childhood and adolescence: two patients and review of the literature of associated diseases. European Journal of Pediatrics  2009; 168:1-9 PMID: 18830624

T. Hospach, J.P. Haas, H.I. Huppertz,  R. Keitzer, H. Michels, R. Trauzeddl, D. Föll,  G. Dannecker, G. Horneff:
Stellungnahme der Gesellschaft für Kinder- und Jugendrheumatologie zur Meldung der US-Food and Drug Administration (FDA) über Fälle von Malignomen bei Anti-TNF behandelten Patienten. Zeitschrift für Rheumatolologie 2009; 68:162-164

T. Hospach, J.P. Haas, H.I. Huppertz,  R. Keitzer, H. Michels, R. Trauzeddl, D. Föll,  G. Dannecker, G. Horneff:
Meldung der FDA über Fälle von Malignomen bei Anti-TNF-behandelten Patienten - Stellungnahme Monatsschrift Kinderheilkunde 2009; 157:373-376

T. Hospach, M. Langendörfer, T. von Kalle, F. Tewald, T. Wirth, G.E. Dannecker:
Mimicry of lyme arthritis by synovial hemangioma. Rheumatology International 2009; 10.1007/s00296-009-1320-x

2008

Bielack S:
Pediatric extraskeletal osteosarcoma. Pediatr Radiol 2008;38(9):1033.

Bielack S, Carrle D, Jost L:
Osteosarcoma: ESMO clinical recommendations for diag-nosis, treatment and follow-up. Ann Oncol 2008;19 Suppl 2:ii94-6.

Bielack SS, Carrle D:
State-of-the-art approach in selective curable tumors: bone sarcoma. Ann Oncol 2008;19 Suppl 7:vii155-60.

Bielack SS, Carrle D, Hardes J, Schuck A, Paulussen M:
Bone tumors in adolescents and young adults. Curr Treat Options Oncol 2008;9(1):67-80.

Bielack SS, Marina N, Ferrari S, Helman LJ, Smeland S, Whelan JS, Reaman GH:
Osteosarcoma: the same old drugs or more? J Clin Oncol 2008;26(18):3102-3; author reply 3104-5.

Dantonello TM, Int-Veen C, Leuschner I, Schuck A, Furtwaengler R, Claviez A, Schneider DT, Klingebiel T, Bielack SS, Koscielniak E; CWS study group; COSS study group:
Mesenchymal chondrosarcoma of soft tissues and bone in children, adoles-cents, and young adults: experiences of the CWS and COSS study groups. Cancer 2008;112(11):2424-31.

Dantonello TM, Int-Veen C, Winkler P, Leuschner I, Schuck A, Schmidt BF, Lochbueh-ler H, Kirsch S, Hallmen E, Veit-Friedrich I, Bielack SS, Niggli F, Kazanowska B, La-denstein R, Wiebe T, Klingebiel T, Treuner J, Koscielniak E:
Initial patient characteris-tics can predict pattern and risk of relapse in localized rhabdomyosarcoma. J Clin On-col 2008;26(3):406-13.

Heinsohn S, Szendroi M, Bielack S, Stadt UZ, Kabisch H:
Evaluation of SV40 in osteosarcoma and healthy population: A Hungarian-German study. Oncol Rep 2009;21(2):289-97.

Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F:
Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin On-col 2008;26(9):1504-10.

Jasnau S, Meyer U, Potratz J, Jundt G, Kevric M, Joos UK, Jürgens H, Bielack SS; Cooperative Osteosarcoma Study Group COSS:
Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group. Oral Oncol 2008;44(3):286-94.

Kersting C, Agelopoulos K, Schmidt H, Korsching E, August C, Gosheger G, Dirksen U, Juergens H, Winkelmann W, Brandt B, Bielack S, Buerger H, Gebert C.
Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth fac-tor receptor gene (EGFR) in high grade central osteosarcomas. Genes Chromosomes Cancer 2008;47(8):657-64.

Klingebiel T, Boos J, Beske F, Hallmen E, Int-Veen C, Dantonello T, Treuner J, Gadner H, Marky I, Kazanowska B, Koscielniak E:
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer 2008;50(4):739-45.

Kraus M, Malenke E, Gogel J, Muller H, Ruckrich T, Overkleeft H, Ovaa H, Koscielniak E, Hartmann JT, Driessen C:
Ritonavir induces endoplasmic reticulum stress and sen-sitizes sarcoma cells toward bortezomib-induced apoptosis. Mol Cancer Ther 2008;7(7):1940-8.

Paulussen M, Bielack S, Jurgens H, Jost L:
Ewing's sarcoma of the bone: ESMO clini-cal recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008;19 Suppl 2:ii97-8.

Reinhard H, Reinert J, Beier R, Furtwangler R, Alkasser M, Rutkowski S, Frühwald M, Koscielniak E, Leuschner I, Kaatsch P, Graf N:
Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany. Oncol Rep 2008;19(3):819-23.

Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, Dirksen U, Lanvers-Kaminsky C, Juergens H, Herrero D, Stegmaier S, Koscielniak E, Eggert A, Nathrath M, Gosheger G, Schneider DT, Bury C, Diallo-Danebrock R, Ottaviano L, Gabbert HE, Poremba C:
Microarray analysis of Ewing's sarcoma family of tumours reveals charac-teristic gene expression signatures associated with metastasis and resistance to che-motherapy. Eur J Cancer 2008;44(5):699-709.

Weihkopf T, Blettner M, Dantonello T, Jung I, Klingebiel T, Koscielniak E, Lückel M, Spix C, Kaatsch P:
Incidence and time trends of soft tissue sarcomas in German chil-dren 1985-2004 - a report from the population-based German Childhood Cancer Regis-try. Eur J Cancer 2008;44(3):432-40.

Borgmann A, Zinn C, Hartmann R, Herold R, Kaatsch P, Escherich G, Möricke A, Henze G, von Stackelberg A; ALL-REZ BFM Study Group:
Secondary malignant neo-plasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur J Cancer 2008;44(2):257-68.

Hospach, T., G. Klaus, K. Holl-Ulrich, G.E. Dannecker, G. Horneff:
Purpura Schoenlein-Henoch - Ergebnisse der Wörlitzer Konsensusgespräche 2005 zum diagnostischen und therapeutischen Vorgehen. Klinische Pädiatrie, 2008; 220: 47-52

Hospach, T., G. Dannecker:
Symptomatik, Diagnostik und Differentialdiagnostik von Arthritiden im Kindes- und Jugendalter. Kinder- und Jugendarzt 2008; 39:176-187.

2007

Stohr, W, Paulides, M, Bielack, S, Jurgens, H, Treuner, J, Rossi, R, Langer, T, Beck, JD:
Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer 2007;48(4):447-52.

Stohr, W, Paulides, M, Bielack, S, Jurgens, H, Koscielniak, E, Rossi, R, Langer, T, Beck, JD:
Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system. Pediatr Blood Cancer 2007;48(2):140-7.

Paulides, M, Dorr, HG, Stohr, W, Bielack, S, Koscielniak, E, Klingebiel, T, Jurgens, H, Bolling, T, Willich, N, Sauer, R, Langer, T, Beck, JD:
Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System. Clin Endocrinol (Oxf) 2007;66(5):727-31.

Kratz, CP, Steinemann, D, Niemeyer, CM, Schlegelberger, B, Koscielniak, E, Kontny, U, Zenker, M:
Uniparental disomy at chromosome 11p15.5 followed by HRAS muta-tions in embryonal rhabdomyosarcoma: lessons from Costello syndrome. Hum Mol Genet 2007;16(4):374-9.

Kersting, C, Gebert, C, Agelopoulos, K, Schmidt, H, van Diest, PJ, Juergens, H, Winkelmann, W, Kevric, M, Gosheger, G, Brandt, B, Bielack, S, Buerger, H:
Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome. Clin Cancer Res 2007;13(10):2998-3005.

Kazanowska, B, Reich, A, Stegmaier, S, Bekassy, AN, Leuschner, I, Chybicka, A, Koscielniak, E:
Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdo-myosarcoma in children. Fetal Pediatr Pathol 2007;26(1):17-31.

Heinsohn, S, Evermann, U, Zur Stadt, U, Bielack, S, Kabisch, H:
Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma. Int J Oncol 2007;30(5):1205-14.

Hanke, CA, Roessler, J, Stegmaier, S, Koscielniak, E, Niemeyer, CM, Kontny, U:
Alveolar rhabdomyosarcoma mimicking lymphoma with bone marrow involvement. Eur J Pediatr 2007;166(5):505-6.

Gieseke, F, Schutt, B, Viebahn, S, Koscielniak, E, Friedrich, W, Handgretinger, R, Muller, I:
Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs in-dependently of IFNgammaR1 signaling and IDO expression. Blood 2007;110(6):2197-200.

Bielack, S, Kager, L, Zoubek, A:
Skip metastases in osteosarcoma. Electronic letter to: Heck RK Jr., Peabody TD, Simon MA: Staging of Primary Malignancies of Bone. CA Cancer J Clin 2007;(e-letter).

Unruh, A, Fitze, G, Janig, U, Bielack, S, Lochbuhler, H, Coerdt, W:
Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report. J Pediatr Surg 2007;42(9):1623-6.